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ABS.TRACT
Goldberg, Ronald Lee. Ph.D., University of Rhode Island, 1980.
A mechanism of action of gold in rheumatoid arthritis: a biochemical and morphological investigation of the direct effect
of gold sodium thiomalate (GST) on human synovial cells in culture. Major Professor: Dr. George C. Fuller.

Gold sodium thiomalate (GST) effects on cultured rheumatoid synovial cells were used as a model to investigate a mechanism which can explain clinical benefits gained by patients
from gold therapy.

Synovial tissue obtained from patients with

rheumatoid arthritis who were undergoing reconstructive joint
surgery was used to obtain explant culture of synovial cells.
The experiments described were performed on growing monolayer
cultures during the second to fifth passages.

Synovial cells

were exposed to GST at pharmacologically relevant concentrations (10-100 uM).

Vacuoles were found by phase contrast micro-

scopy in synovial cells in culture after 2 days of exposure to
100 uM GST.

The vacuoles,aurosomes, were found to contain

electron dense material by electron microscopy that contained
gold as identified by X-ray probe analysis.

The structure of

the aurosomes, electron dense lamellae structures in membrane
bound vesicles, was found to be similar to those found in
synovial tissue of patients with rheumatoid arthritis who had
received gold therapy.

The time course for gold accumulation

in the cell layer paralleled with aurosome formation and the
degree of inhibition of [ 3 H]thymidine incorporation into DNA.

ii

DNA synthesis, DNA content and cell number were decreased in
a dose dependent manner after synovial cells were exposed to
GST containing medium.

The synthesis of medium proteins per

flask by synovial cells was decreased in a dose dependent
manner with collagen decreased to a greater extent. The percentage of collagen to total protein synthesized by synovial
cells was decreased in a dose dependent manner.

A biphasic

response of an increase followed by a decrease of proteins
synthesized per cell or per DNA unit was found due to GST exposure.

The increase in collagen protein per cell was found

to be predominantly type I collagen.

The percentage of type

III collagen decreased due to synovial cells exposure to GST
containing medium. Removal of GST from the medium resulted
in recovery of biochemical parameters at low concentrations
and a partial recovery at high concentration.

Neither auro-

somes nor gold could be completely removed from synovial cells
after medium changes and subculturing.

An important thera-

peutic mechanism of action of gold in the treatment of patients with rheumatoid arthritis may be by directly inhibiting synovial cells proliferation and altering protein synthesis by synovial cells to a nonconducive matrix for pannus
expansion.
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I.

INTRODUCTION

Gold has been used for half a century to treat rheumatoid
arthritis (RA} .

Although the rationale for the introduction

of gold compounds into therapeutics was based upon gold's

bac~

tericidal property, RA has not been established to oe bacterial in origin and gold does· not eradicate tfie bacterial infections in laboratory· animal models· of RA.

Therefore, the in--

troduction of gold salts in treating RA is not now believed
to be related to the original proposed mechaniS1ll of action
of the agent.

The efficacy· of gold therapy, chrysotherapy,

has firmly been established in several double Blind studies.
Theories dealing with the mechanism of action of gold are
concerned with the interaction of gold with ·inflanunatory
and immunological process-es-.

No single theory can fully ex-

plain the clinical benefits RA patients derive from chrysotherapy.
Animal and cell culture models are used to study RA,
but no single model can reflect the· complex disease of human
RA.

Because rheumatoid hyperplastic synovium, the pannus,

invades· the surrounding connective tis-sue of the joint,
gold's therapeutic effect may be related to a direct effect
on the proliferating synovial cells.

To tes·t this hypothesis,

gold sodium thiomalate CGSTl at pharmacologically relevant
concentrations· was added to the medium of synovial cells derived from RA patients' synovial tissue, pannus, explants.

2

In this model, the synovial cells developed an analogous gold
induced morphological change in vitro as was found in gold
treated patients' synovial cells in vivo.

The biochemical

changes in gold-exposed synovial cells reported in this dissertation may be important factors in the efficacy of gold in
RA.
A better understanding of the mechanism of action of a
proven therapeutic drug will hopefully lead to the development of a more efficacious, less toxic drug and a better
understanding of the pathophysiology of rheumatoid arthritis.
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II.
A.

LITERATURE SURVEY

Rheumatoid Arthritis
Among the diseases which cause chronic loss of func-

tional capabilities, arthritis and rheumatism are second only
to cardiovascular diseases.

"There is no othe·r group of di-

seases which causes so much suffering by so many for so long
(Hollander, 1972) ."

Approximately 5% of the total world pop-

ulation are affected and over 11 million Americans suffer
from rheumatism and arthritis.

Of these, osteoarthritis,

degenerative joint disease, is the most common, but rheumat~id

arthritis (RA) is a greater problem with regard to

severity and prolonged disability.

Arthritis rarely kills;

it is the life-long crippling rather than mortality that is
the problem.
1.

Etiology of rheumatoid ·a rthr.i tis.
The etiology of rheumatoid arthritis (RA) is still

an enigma.

Theories· for the origin of RA include infections,

metabolic, nutrition, endocrine, autoimmune,

trauma, ~ environ

mental, psychosomatic, genetic and a multifactoral of the
above.

According to Person and Sharp (1977), RA is a

con~

venient designation to describe a clinically, serologically
and etiologically heterogenous group of conditions.
An analogous disease to human RA can be produced in animals by bacterial infection (Cecil et· al., 1939 and Timoney

4
and Berman, 1970).

Similarly, mycoplasma, viruses and anti-

genic proteins can elicit inflammatory joint reactions
(Consden et al., 1971; Cooke et al., 1974; Currey, 1970;
Stuart et al., 1979 and Chambers and Bywaters, 1963).

The

infective agent (or the antigen) cannot always be cultured
or found in the inflamed joint (Cole et al., 1973 and Person
et al., 1973).

Therefore, the initial trigger for RA need

not be associated with the joint or the patient during the
active disease process.

The transfer of homologous nodules

in laboratory animals does not cause a rheumatoid-like arthritis.

Even the transfer of serum or synovial fluid from

RA patients to non-RA patients does not transmit the rheumatic disease (Harris and Vaughan, 1961) .
There may be a . genetic predisposition to RA (Wasmuth
et al., 1972).

Unlike ankylosing spondylitis which is linked

with the HLA-B-27A loci (Pasternack and Tulikaine, 1977),
there is only a modest increased frequency of HLA-Dw3 and
HLA-Dw4 loci (McMichael et al., 1977) found associated with
RA patients (4 times more often than non-RA controls).

The

classic rheumatoid factor (RF) , IgM antibodies directed
against IgG, is associated with 70-80% of RA patients but
is not specific to RA.

Patients with bacterial endocarditis

and systemic lupus erythomatosis often are RF positive as is
5% of the normal healthy population (Bartfeld, 1969 and
Williams, 1974).

These again point to RA as a heterogenous

disease with possible different origins and a multifactoral
etiology with a common manifestation of RA.
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2.

Pathogenesis of rheumatoid arthritis.
Although the etiology of RA is unknown, much is known

about the pathogenesis of this disease.

The defense mecha-

nisms of the body, both humeral and cellular immunity, play
important roles in the pathogenesis of RA.

An initial syno-

vi tis (of unknown origin) evokes an immunological sequel of
events that result in antibodies to autoantigens.

Antibodies

directed against (self-components) nucleic acids, collagens,
fibrin and lymphocytes have been found in the serum and synovial fluid of RA patients (Osgood, 1976 and Williams, 1974).
The primary of fending agent is thought to be antibodies directed against the Fe portion of the Y-globulin (IgG)
and Munths, 1975).

(Natvig

Seropositive RA patients are defined as

patients with immunoglobulin M (IgM) antibodies, directed
against IgG.

These antibodies have been identified as the

classical rheumatoid factor.

Both seropositive and sero-

negative patients have a rheumatoid factor consisting of
IgG anti-IgG.

When these autoantibodies reach a critical

titer, they form immune complexes in the synovial fluid and,
to a lesser extent, in the synovial tissues (Natvig and
Melblye, 1979).

Normal synovial fluid usually has the same

amount of compliment (C) activity as found in serum, but
rheumatoid joint fluid has a depleted level of C activity
due to activation of both the classical and alternate C
pathways by the immune complexes.

High concentrations of

the chemotactic factors for granulocytes (C3a, CSa and C567)
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are formed in the activation of the C pathway (Ward and
Zvaifler, 1971).

A large number of neutrophils polymorpho-

nuclear cells (PMNs) , infiltrate the inflamed rheumatoid
joint synovium.

However, most are found in the synovial

fluid where the neutrophils phagocytize large amounts of C3
and immune complexes.

Inflammatory mediators and hydrolytic

enzymes are released from the phagocytosing neutrophils
(regurgitation during feeding or cell death) that perpetuate
the inflammation and subsequently degrade the cartilage connective tissues.

Attracted mononuclear cells, lymphocytes

and macrophages, infiltrate the edematous, hypertrophied
and hyperplastic synovial tissue.

Lymphocytes proliferate

in synovial tissue and sometimes form germinal centers
around blood vessels, as in a lymph node, where B-lymphocytes become plasma cells to produce more antibodies (e.g.,
rheumatoid factors) that perpetuate the disease.

Most of

the lymphocytes in the synovium are T-lymphocytes (75%).
The cellular immunity, delayed type hypersensitivity,
is very important in the pathogenesis of RA (Natvig and
Mellbye, 1979).

The subpopulation of T-cells and their

functions include:

k-cells, killer cells which are cyto-

toxic to other cells by direct contact; h-cells, helper
cells that cooperate with B cells in antibody production,
and s-cells, suppressor cells that modulate the B cell antibody production.

A lack of suppression by the s-cells to

allow the production of forbidden clone(s) appear to be an
import~nt

factor in the development of the RA lesion
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(Tannenbaum and Shur, 1974).
of lymphokines.

Lymphocytes elaborate many types

Factors like macrophage inhibitory factor

(MIF) keeps macrophages in the inflamed synovium.

Lymphokines

can stimulate macropages to release factors which cause the
lymphocytes to proliferate.

Lymphokines injected into a rab-

bit joint causes a rheumatoid-like arthritis, and lymphokines
or mononuclear cell factors can stimulate synovial cells to
proliferate and produce collagen in culture (Stastny et al.,
1975).

Inflammatory mediators and modulators including

bradykinins, histamine, seratonin, SRS-A, platelet factors
and prostaglandins interact synergistically to perpetuate
the inflammation.

Positive feedback loops with immunologi-

cal and inflammatory cells and immunological and inflmmatory
factors perpetuate the disease resulting in swelling and
pain (Zvaifer, 1970 and 1973).

Eventually, the hyperplastic

synovium invades other connective tissue compounds (cartilage,
bone or ligaments) and is then called a pannus (Harris, 1974,
1976 and Harris et al., 1972).

At the edge of the pannus,

proteolytic enzymes including mammalian collagenase have
been identified by immunofluorescence (Wooley et al., 1975
and 1977).

Irreversible damage occurs when the pannus en-

zymes digest the structural protein collagen.

Pannus growth

may be stopped by either blocking the stimulatory factors
that promote the growth of the granulation type tissue, preventing the formation of the granulation extracellular matrix,
blocking enzyme release at the edge of the pannus or inhibiting synovial cell division.

Preventing the irreversible

8

joint damage due to the pannus is important because eventually the damage could lead to loss of function of the joint.
3:

Pharmacoloqic·a 1 Man·a geinent o"f rheuma tbid" ·a rthritis.
At present no drugs are known to adequately control

chronic inflammatory diseases like RA in all clinical situa-·
tions.

Drugs used today only suppress the disease.

Thera~

peutic management of RA is to reduce inflammation and pain,
with attempts to maintain function and prevent deformities.
In treating the RA patient, drug therapy is only one compo-·
nent of the management.

Physical therapy, nutrition and

psychology for chronic, possioly disabling, disease are also
important.
a.

First line drugs
Nonsteroidal anti-inflanunatory agent (NS"AIAJ are

the first line drugs us·ed to treat RA.

The NSAIA were

thought to work by uncoupling oxidative ·phosphorylation
(Whitehouse, 1963); h_o wever, -more specific drugs for uncoupling oxidative phosphorylation \e.g., dinitropheriolJ. are not
anti-inflanunatory.

The present theory most widely accepted

for NSAIA mechanisms of action is inhibition of prostaglandin
synthesis (Vane,

1~71J

.

NSAIA drugs decrease the edema

whicn causes the pain in morning stiffnes-s and are -mild

anal~

gesics. Salicylate therapy, especially aspirin, is- used
primarily because of low toxicity, efficacy and -mini-mal
pense.

ex~

If toxicity or lack of efficacy is found w-ith aspirin,

other NSAIA such as indometh.acin are used.

More potent drugs
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are used alone or in conjunction with the NSAIA in the more
severe cases of RA.
b.

Steroids
When the inflammation of RA is not controlled

by NSAIA, steroids are sometimes used.

The mechanism of ac-

tion was thought to be via lysosomal membrane stabilization
(Symons et al., 1961) but Ignarro (1972) presented evidence
that this is an in vitro artifact. Anti-inflammatory steroids
as well as hormonal steroids have been shown to bind to a
cytoplasm receptor.

The steroid-receptor "active complex"

is transported to the nucleus resulting in the repression
and activation of transcription of mRNAs from DNA (Haynes
and Larner, 1975).

One of the pharmacological properties of

hormonal and anti-inflanunatory steroids is selective gene
expression for protein synthesis.

Inhibition of lymphocyte

proliferation and lymphokine production (Weston et al., 1973
and Kayashima et al., 1978) and inhibition of prostaglandin
release (Lewis and Piper, 1975) by blocking the phospholipase
enzyme have also been proposed to explain the action of antiinflammatory steroids. A long-term hazard of systemic corticosteroids, Cushing's disease, makes steroid therapy a controversial form of treatment (Hess and Goldman, 1972 and
Dayer et al., 1976).

The intraarticular injection of ster-'

oids are useful and decrease the systemic problems associated with the systemic use of this drug (Hess and Goldman,
1972).

Neither steroids nor NSAIA prevent the progression
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of the pannus (Harvey, 1975), and therefore cannot prevent
irreversible erosion causing the disabling consequence of
the illness.
c.

Second line drugs
Second line drugs are generally drugs used in

chronic erosive disease which are characterized by a delay
in onset of therapeutic action and a slow return of symptoms
after termination of drug use.

Hydroxychloroquine, gold

salts and penicillamine all have severe side effects that need
to be monitored, but there also is data to suggest these
drugs inhibit the erosive consequence from the pannus (Cooperative Clinic Conunittee ARA, 1973; Multicenter Trial Group,
1973 and Mainland and Sutcliffe, 1962).

The early signs of

toxicity with gold salts and penicillamine are a pruritic
dermatitis and a proteinuria which are reversible.

Bone mar-

row suppression is the most dangerous side effect (Harvey,
1972) and with hydroxycloriquine retinopathy leading to
blindness can occur (Zvaifler, 1968 and Rubin et al., 1963).
A sul5set of second line drugs include cytotoxic drugs.
Cyclophosphamide and azathioprine were first used as anticancer drugs and are carcinogens.

It is thought that these

drugs are immunosuppressive and prevent pannus progression
(Urowitz, 1974).

The use of these drugs is restricted to

only the most resistent cases ("Cooperative Clinic Committee
ARA, 1970).

11
B.

Animal Models for Rheumatoid Arthritis
1.

Adj uvant rat -model.
No one experimental model has all the

tics of human RA.

characteris~

The animal model -most commonly used is

the rodent adjuvant arthritis [Stoerck et al., lg54}.

This

is a polyarthritis that can be induced by a single i.p. injection of killed mycobacteria or tuberculin [Currey, 1970).
The antigen responsible is the peptidoglycan of max D (Adam
et al., 1972) from the bacteria cell wall.

The suppressor

T-lymphocytes play a major role in the development of the
disease (Kayashima et al., 1978).

Even though many similar-

ities exist between this model and human RA, rheumatoid
nodules and rheumatoid factor are not present ("Pearson, 1972) .

2.

Antigen rabbit model.
Another model is the antigen-·induced arthritis in

rabbits.

The rabbit is immunized with a protein antigen,

e.g. fibrin (Dumonde and Glyn, 1962).
the antigen is injected into the joint.

Several weeks later
A monoarticular

arthritis develops with neutrophils and mononuclear infiltrates.

Immunoglobulin synthesis by lymphocytes in the sy-

novial tissue are directed against the challenge antigen
(Cooke and Jasin, 1972 and Cooke and Richer, 1974).

The

histology of the synovial tissue in this model is very similar to the pannus, though in human RA there is usually a
polyarthritis.
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3.

Collagen induced arthritis.
Recently, a type of rodent arthritis was found to

be caused by injection of collagen.

Native but not denatured

type II collagen injected subcutaneously caused a polyarthritis in rats (Stuart et al., 1979a, b).

A similar model of

collagen induced arthritis was also induced in rabbits
(Steffen et al., 1979). Collagen induced arthritis might
have clinical relevance.

Andriopulous et al.

(1976) found

antibodies against type II collagen in the sera of patients
with RA. The antibody titers were highest against denatured
rather than native types II and I collagen.

It is unlikely

that collagen is the unknown trigger antigen in RA.

Rather

the breakdown of cartilage by the pannus releasing type II
collagen acts as an antigen which perpetuate the inflammation.
Gardner (1960) reviewed the experimental models for RA
and classified them into five groups, infective, chemical,
immunological, endocrine and physical.

His conclusion that

because of the lack of resemblance to human RA, that future
investigations should be conducted with human tissue is still
true two decades later with the newer animal models.

c.

Human Synovial Tissue and Cells in Culture
1.

Tissue.
The diathroid (free moving)

joint has two periosteal

bones covered at their articular end with hyaline cartilage,
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held together by fibrous ligaments, which form a joint capsule.

The inner lining of the joint capsule has a one to

three cell layer thick membrane called the synovial membrane.
Synovial fluid is a viscous translucent yellow-colored liquid within the diathroid joint.

The composition of synovial

fluid is an ultrafiltrate of plasma plus protein, glycosaminoglycans and a hyaluronic acid secreted by the synovial
cells.

The synovial cells also keep the synovial fluid

clear by phagocytosis of particulate matter and invading
organisms.

2.

Cells and culture models.
Three cell types have been characterized in the

synovial membrane (Barland et al., 1962).

Type A cells are

phagocytic macrophage like cells with many vacuo1.es. Type
B cells

a~ e

fibroblast-like cells with abundant rough endo-

plasmic reticulum. Type C cells are either precursors or
an intermediate between type A and B cells.
Two techniques are currently used for initiating synovial cell cultures.

One is the enzymatic release adhesion

method; the other is the explant method.

Both methods

result in heterogeneous cell populations in culture (Marsh
et al., 1978).
a.

Enzymatic release-adhesion
The enzyme release adhesion method results in

primary cultures of cells which are dissociated from the
tissue with collagenase and trypsin. The cells are inocu-
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lated into the medium in a cell culture f lask.

After an

hour the medium is removed and the cells attached to the
flask are used for the cultures.

These cell s produce rela-

tively large quantities of collagenase and prostaglandins
(Dayer et al., 1976).

Some adherent synovial cells

(ASC)

assume a stellate morphology in culture but do not possess
the immunoglobulin (EA) or compliment (EAC) r .eceptors
(Dayer and Krane, 1978).
b.

Explant
The explant culture method first described by

Vaubel (1933a, b) produces heterogenous populations of cells
that grow out on the culture plate from a · small minced
piece of synovial tissue.

These cells produce mucopoly-

saccaride, hyaluronic acid and collagen (Castor, 1957 and
1970) •

These observations are compatible with the conclu-

sion that for the study of enzymatic activity, the protealytic release-adherent cell culture model would be used,
and that for the synthesis of connective tissue components,
the explant method would be a preferred cell culture model.
Frazer et al.

(1979) described a type 1 and 2 pattern

of changes with synovial cells derived from primary culture
explants.

The type 1 response consists of increased vacu-

oles, increased degradation enzymes and decreased hyaluronic
acid obtained with sucrose (8mM), adenosine (0.4mM) and
serum (50% v/v). The type 2 response consists of increased
hyaluronic acid synthesis and dendrite formation obtained
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by increasing intracellular c-AMP (cholera toxin and dbc-AMP)
and carrageenin (Clarris et al., 1979).
Glen-Bott (1972) examined the ultrastructure of synovial
cells in situ and in culture.

Because of the substantial dif-

ference, he concluded that culture cells do not reflect their
function in vivo.

There are certain functions that synovial

cells do retain in culture as stated above, but still one
should be cautious in the interpretation.
By definition, synovial cells are cells derived from synovial tissue.

At present, no biochemical, morphological,

or cell surface markers are used to define a culture as synovial cells.

The relationship of synovial cells in culture

may be related to -the synovial cell ih situ as follows.

The

explant culture method may select for the type B synoviocytes
because in culture these cells produce structural proteins
such as collagen and carbohydrates such as hyaluronic acid.
These cells also have a fibroblast-like morphology with
abundant rough endoplasmic reticulum and golgi apparatus. The
adherent culture method ·may select for the type A synovio..cyte because in culture these cells produce proteolytic enzymes like collagenase, and have abundant vacuoles typical
for a phagocytic cell.

The type 1 and 2 response in culture

may be the commitment or differentiation of a type C cell
to either an A or B synoviocyte which is thought to occur
in vivo.
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c.

Rheumatoid disease in culture:
The human synovial cell culture model has been

used for over forty years to study and better understand rheumatoid arthritis.

It is controversial, however, whether

rheumatoid disease can be brought into culture.

The compari-

son of normal versus rheumatoid-derived synovial cell lines
results in conflicting results.

No morphological difference

was found in the rheumatoid synovial cells by Castor and
Dorstewitz (1966), Waynne-Roberts and Castor (1972) and
Ghose et al.

(1975).

An increase in multinucleated cells,

cytoplasm granulation and media particles in RA synovial
cell was reported by Bartfeld (1965), Goldfisher et al.,
Smith and Hamerman (1969) and Marsh et al.

(1968)

(1974 and 1977).

Castor and Dorstewitz (1966), Smith and Hamerman (1969) and
Marsh et al.

(1974) reported slower doubling and shorter

life span in culture for rheumatoid cells, whereas, Ghose
et al.
-

(_1975) found no difference.

Castor (1973)

found an

increase in low molecular weight hyaluronic acid in the medium of the rheumatoid synovial
rheumatoid.

cel~ls

relative to the non-

This particular change is characteristic of

the synovial fluid in RA.

Vuorio (1977) confirmed the above

changes in rheumatoid and nonrheumatoid synovial cells and
also found a 75,000 dalton membrane protein only in rheumatoid synovial cell membranes. Smith (1970) reported a growth
inhibitor (GI)

in rheumatoid synovial cells.

Possibly the

growth inhibitor is reponsible for slower doubling times
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of rheumatoid cultures.

The heterogenity of rheumatoid di-

sease and the heterogenity of synovial cells make it difficult, so far, to have a parameter as an indicator for RA
synovial cells.
3.

Peptide modulators effects in culture.
The addition of endogenous peptides can modulate

cell metabolism. Castor (1971) first described connective
tissue activating peptide (CTAP) which was derived from leukocytes.

CTAP increased glucose uptake, lactic acid forma-

tion and hyper-production of low molecular weight hyaluronic
acid.

Castor et al.

-

-

ferent types of CTAP:

(1979) have described at least four difCTAP-I from lymphoid tissue, CTAP-II

from a tumor cell line, CTAP-III from platelets, and CTAP-ex
from neutrophils.
Korn et al.

(1980) found that mononuclear supernates

(MCS) stimulated PGE 2 production and suppressed proliferation
of human dermal fibroblasts.
blasts and Parrott et al.

Wahl et al.

(1978) with fibro-

(1980) with synovial cells found

MCS to stimulate proliferation and collagen synthesis.
Jimenez et al.

(1979)

sis .. of fibroblasts.
and activators in the

found MCS inhibited

collagen synthe-

There are (pr.esumably) both inhibitors
MCS~

Inhibition or activation depends

upon the preparation and the cells used.
Burke and Ross (1977), Kohler and Lipton (1974) and
Castor et al.

(1979) found platelet factors to stimulated

synovial cells and fibroblast proliferation.

Collagen
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synthesis was increased with platelet factors (Burke and
Ross, 19 77) •
One of the problems of bringing the rheumatoid disease
into culture is the possibility that "normal" synovial cells
placed into an environment conducive to proliferation may behave like rheumatoid cells.

Factors (peptides) found in

fetal calf serum may have many of the stimulatory and inhibitory factors described above.

The only differences in rheu-

matoid and nonrheumatoid cell lines may be the enrichment of
a certain cell population in the cultures derived from RA
patients.
4.

Effect of Antirheumatic drugs on cells in culture.
The addition of antirheumatic drugs to cells in cul-

ture is a means of studying changes that may be related to
their mechanisms of action.

Castor (1972) found the effect

of CTAP was blocked by corticoid, NSAIA and adrenergic blocking drugs (Castor, 1975).

Colchicine, choroquine and gold

sodium thiomalate were ineffective.

Rheumatoid cells were

reported to be less responsive than normal synovial cells to
hydrocortisone stimulation of proliferation and inhibition
of hyaluronic acid synthesis (Castor and Drowitz, 1966).
Ponec et al.

(1979) reported that

glucocortico~teroids

de-

creased collagen synthesis without effecting hydroxylation.
Bayer et al.

(1979) reported that indomethacin reversibly

blocked cell proliferation in the G phase. Schorn et al.
1
(1979) reported that penicillamine suppresses collagen
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biosynthesis which may be related to the patient's clinical
improvement of rheumatoid arthritis.

The effects of drugs

in culture or in vitro are a good indication of mechanism
but are not proof (i.e., membrane stabilization with steroids (Ignarro, 1972)).

D.

Role of Collagen
1.

Structure and synthesis.
Collagens are the structural proteins of the extra-

cellular matrix.

They consist of three polypeptides, a chains,

circa 1000 amino acid long twisted into a helix, l.5nMX300nM.
Only short sequences at each end are nonhelical.

In the

helical region the molecular formula is (gly-X-Y)333.
Y is proline, it is usually hydroxylated.

When

The hydroxylation

of proline is important for a stable helix at body temperature.

Imino acids account for 25% of the residues in colla-

gen, limiting the rotation of the polypeptide backbone
(Ramachandran and Ramakrishnan, 1976, and Kivirikko and
Risteli, 1976).
Collagens are first synthesized as 40% larger procollagens a chains.

After the message is transcribed from the

DNA, the rnRNA is translated on polyribosomes.

While the

nascent chain is being elongated into the rough endoplasmic
reticulum cisterne, some proline and lysine residues are
hydroxylated by prolyl and lysl hydroxylases.

Some hydroxy-

lation also occurs as the procollagen is transported to the
smooth endoplasmic reticulum and the golgi apparatus.

Sites
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of glycosylation are on hydroxylated lysine residues.

The

carboxy terminal procollagen extensions have cystein residues that hold three procollagen together for helix formation (Byers et al., 1975).

Helix formation is necessary

for rapid secretion of functional protein.

Some of the pro-

collagen produced may be aggregated and degraded intracell ularly (Prockop et al., 1979, Brenkowski et al., 1978).
Once the procollagens are secreted, extracellularpost-translational modifications take place (Goldberg et al.,
1975).

The procollagen peptides are cleaved at both the

amine and carboxy terminal by procollagen peptidases.

The

collagen aggregates are assembled in a quarterstagger model
into fibrils.

Lysl oxidase oxidatively deaminates lysine

residues leaving aldehyde moieties which participate in
intra- and intermolecular covalent crosslinks.

Crosslink-

ing decreases the solubility, increases the tensile strength
and decreases the susceptibility of collagen fibers to degradation by collagenases (Prockop et al., 1979; Fuller and
Mann, 1980 and Tanzer, 1976 and Bailey et al., 1974).
2.

Types of collagen.
Five types of collagens requiring seven different

genes have been described.

Primary structure differences

underlies differences in the extent of posttranslational
modifications, and therefore, the function of each collagen
type.

Only recently are the relationship of collagen types

to tissue differentiation and disease processes being elucidated (Eyre, 1980; Fuller and Mann, 1980, and Lapiere and
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Nusgens, 1976).
Collagen has a nonconventional protein nomenclature. The
Greek letter a , 8 and y mean monomer, dimer and trimer.

The

tertiary structure of the collagen molecule is a trimer but
separation of denatured collagen results in a ,

s,

y

and

higher molecular weight forms due to lysine and histadine
derived covalent intra- (holds together the tertiary structure) and inter- (holds together the quatenary structure)
crosslinks (Tanzer, 1976).
ing the Greek letter a

The arabic numbers (1,2) follow-

indicate the order of the a chain

elution from a carboxymethyl cellulose column for that type
of collagen.

The subscript arabic number is the number of

chains found in the collagen molecule.

The Roman numer-

al (I, II ••• ) indicates the collagen type.
Type I collagen,
forms thick fibrils.
glycosylated.

[ a l(I)] a 2 is found ubiquitously and
2
Only a few of the hydroxylysines are

Bone, tendon, dentin, ligaments and scars are

predominantly type I collagen (Prockop et al., 1979).
Type III collagen,

[al(III) J

3

is usually associated

with type I collagen and is found in greatest abundance in
more elastic tissues such as lung, blood vessels, fetal skin
and granulation tissue.

There is a shift from a type III

to a type I collagen predominance with the maturation of
skin from fetal to adult as well as in the transformation
from granulation tissue to scar tissue (Epstein, 1974,
Epstein and Munderlok, 1975, and Bailey et al., 1973 and 1975).
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Fine reticulin fibers contain type III collagen but this
collagen is not the basis for the histological silver staining (Norwalk et al., 1974 and Timple et al., 1977).

Type

III collagen has a low hydroxylysine and carbohydrate content
but a high hydroxyproline content.

The three a l(III) chains

are held together by disulfide bonds at the end of the helical region of the carboxy terminal (Chung and Miller, 1974).
Type II collagen is found in only a few tissues like
cartilage, vitreous body and cornea which are soft tissues
with a high water content.
chains [ al(II)J
thin fibrils

3

It consists of three

which are highly

and form

(Miller, 1976).

Type IV collagen [ a 1 (IV) ]
lagen.

glyco~ylated

a l(II)

3

is a basement membrane col-

This collagen has a high hydroxylsine content nearly

completely glycosylated, a low alanine content and retains
much of the procollagen nonhelical extension pieces (Jaffe
et al., 1976 and Eyre, 1970).

Metastatic tumors produce

collagenases specific for this collagen (Liotta et al., 1977
and 1979).
A type V collagen has recently been characterized
(Burgeson et al., 1976).

The molecular composition may be

a A [ (aB)]

or (a A)
and (a B)
(Rhodes and Miller, 1978;
2
3
3
Deyl et al., 1979).
(Type V collagen has not to date been
given the typical collagen nomenclature.)

This collagen is

found ubiquitously but in small amounts.

Type V collagen is

thought to be a cell surface collagen and may be important
in cell migration (Eyre, 1980 and Stenn et al., 1979).
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A type I trimer,

[ a {I)J

3

has been reported in inflamed

gingiva and is produced by cells in culture (Little et al.,
1977, Benya et al., 1977 and Narayanan et al., 1978).

This

may be an altered type I collagen or a different gene product of a l(I) with similar composition (Eyre, 1980).
3.

Alteration of collagen types with disease.
In some diseases there is an alteration of the

tissue composition of collagen types.

In some cases the al-

teration may be the primary lesion as in Ehlers-Danlos syndrome and osteogenic imperfecta or part of the pathogenesis
as in cirrhosis and arteriosclerosis.

In Ehlers Danlos syn-

drome type IV, there is a lack of type III collagen synthesis (Pope et al., 1976).

In osteogenesis imperfecta, skin

cells synthesize a greater proportion of type III collagen
(Penttinin et al., 1975 and Sykes et al., 1977).

In mitral

valve prolapse, ruptured chordae tendinae, Hammer et al.,
(1979) reported an absence of type III and type V collagens.
In diabetes melatus, an increase in the relative synthesis of type III collagen in skin has been reported (Kern
et al., 1979).

In liver cirrhosis, there is an increase in

both type I and III with type I increasing more than type
III collagen (Rojkind and Martinez-Palomo, 1976 and Seyes
et al., 1977).

Similarly, in arteriosclerosis there is an

increase in aorta collagen synthesis with type I collagen
predominating (Fisher et al., 1980 and Mccullagh and Balian,
1975).

With both cirrhosis (Rojkind and Martinez-Palomo,
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1976) and arteriosclerosis (Burke and Ross, 1979) ,as with
granulation tissue (Gay et al., 1978 and Bailey et al:., 1973
and 1975) there is first an increase in type III collagen
followed by an increase in type I collagen.

Gay et al.

(1978) proposed that the mesenchymal cells predominate early
in wound healing and produce predominantly type III collagen,
while later mature fibroblasts predominate and synthesize
more type I collagen.
4.

Synovial collagen.
The data implicating a change in the collagen heter-

ogeneity in the rheumatoid synovium are conflicting.
et al.

(1975)

Weiss

found a higher proportion of type III collagen

relative to type I collagen in the rheumatoid versus the
nonrheumatoid synovium.
Eyre and Muir (1975a)

Their results were criticized by

in that less than 20% of the total

normal synovium collagen was pepsin-acetic acid extracted.
Using a cyanogen bromide extraction, which extracts more
than 80% of the collagen, Eyre and Muir (1975b)

found the

ratios of type I/III collagen to be similar in rheumatoid
and nonrheumatoid synovial tissue.

Both groups agreed the

rheumatoid collagen was more susceptible to pepsin extraction.

Brown et al.

synovial tissue.

(1979) extracted type V collagen from

This collagen represented less than 2%

of the total collagen.

Normal and rheumatoid synovium

have relatively similar amounts.
Subcultured synovial cells in culture produce a similar ratio of type I/III collagen (Parrott et al., 1980 and
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Vuorio, 1979).

The rheumatoid primary cell cultures pro-

duced a greater percentage of type III collagen than the
subcultured cells; also, the rheumatoid cell lines maintained a greater propensity for synthesis of type III collagen than nonrheumatoid cell lines (Parrott et al., 1980).
Again the rheumatoid disease is heterogenous, as are patients.
The factors influencing the types of collagen could be relative to the amount of different cells brought into culture.

The age of the patient and the stage of the disease

in the synovium at the time of the operation, may also influence the cell culture population.

E.

Gold in Rheumatoid Arthritis
1.

Efficacy and Toxicity
Forestier (1929) reported beneficial effects of

gold therapy in RA patients.

Numerous reports followed

con~ 

firming the efficacy of gold in RA but most were not controlled or double blind studies.

Extensive double blind

studies were reported by the Research Subcommittee of the
Empire Rheumatism Council of Great Britain (1960, 1961) and
the Cooperative Clinics Committee of the American Rheumatism Association (1973).

Both groups found that gold

treated patients had stronger grips, decreased erythrocyte
sedimentation rates

(ESR) and fewer involved joints.

The

cooperative clinic did not find radiological improvement
but a longer (2 year) double blind study (Sigler et al.,
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1974) reported significant radiological improvement with regard to the progression of bone and cartilage destruction.
In some patients the disease process was arrested.

The per-

centage of patients benefiting from chrysotherapy is 40-75%
depending upon the study (Freyberg, 1972).
The first sign of gold toxicity is pruritis followed by
dermatitis. · More dangerous common side effects are blood
dyscrasias-thrombocytopenia, leukopenia agranulocytosis and
aplastic anemia.

Patients receiving chrysotherapy may de-

velop a proteinuria which on occasion will warrant discontinuance of gold treatments.

There is no correlation be-

tween toxicity and therapeutics (Harvey, 1975 and Freyberg,
1972).
2.

Pharmacokinetics
a.

Whole body-blood and tissue
Gold sodium thiomalate (GST) does not follow

the classical drug pharmacokinetics.

The gold moiety of

the drug is not entirely eliminated (Gottlieb et al., 1972)
and the blood levels do not correlate with therapeutics
(Gerber et al., 1972) or toxicity (Mascarehas et al., 1972).
The accumulation of gold in the tissues is a more important
parameter than plasma levels (Smith et al., 1958).

The peak

plasma gold level, after an intramuscular injection of GST,
is 4-6 hours.

The half time of elimination is 2-3 weeks,

though higher doses and longer duration of treatment will reduce the rate of elimination (Rubinstein and Dietz, 1973).
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The thiomalate dissociates from gold sodium thiomalate and
is eliminated more rapidly (Jellum et al., 1980).

The mean

blood gold levels attained in chrysotherapy with GST are between 2-5 ug Au/ml serum (Mascarehas et al., 1972 and Lorber
et al. , 19 7 3) •
There are reversible and irreversible deposits of gold
in body tissues.

The kidney, liver adrenals and reticule-

endothelial system have the highest concentrations
et al., 1972).

(Go~tl~eb

The synovial tissue concentration of gold is

20-50 ug/Au/g tissue.

An inflamed synovium accumulates

more gold than a noninflamed synovium (Grahame et al., 1974).
b.

Cellular-aurosomes.
The gold deposited in the tissues is internal-

ized by the cells and sequestered in membrane-bound vesicles.
The gold containing lysosomes have been named "aurosomes" by
Oryschak and Ghadially (1974).

Norton et al.

(1968) de-

scribed membrane bound electron dense material in patients
lysosomes after intra-articular injection of GST.

They re-

ported similar electron dense material after thiomalic acid
injection, though Ghadially (1978) has refuted these later
findings with thiomalic -acid.

The organic thio linked gold

compounds, gold . sodium thiomalate (GST) and gold thioglucose
(GSG) Au( I), form lamellar-like structures in the lysosomes
and gold chloride, HAuC1 4 , Au(III), form aggregates in lysosomes (Ghadially, 1979).

Electron probe X-ray analysis

has confirmed the electron dense material to be gold

28
(Ghadially et al., 1976).

Stone and Galle (1969) observed

gold deposits in kidney tubule mitochondria but further work
is necessary to confirm this observation (Ghadially, 1978).
Penney et al.
tribution of

195

(1976) quantitated the subcellular dis-

Au in Kupffer cells.

The centrifuged frac-

tions corresponding to the nucleus and mitochondria contained
the largest percentage of radioactivity.

The interpretation

of these findings is obscured because gold may alter the
density of the organelle, and the aurosomes may become as
large as a nucleus.

Most of the gold in the cell is bound

(Penney et al., 1975, and Lawson et al., 1977).

The distri-

bution of gold binding to uncharacterized lysomal "macromolecules" was spread over a wide range.

In the cytoplasm,

"macromolecules" of 300,000, 40,000, 10,000 and
.
dalton bound gold (Lawson et al., 1977).

3.

3,000

Pharmacodynamic-mechanism of action.
a.

Protein interaction

i.

Albumin. - Heavy metals have a high affinity

for sulfhydryl groups (Harvey, 1975).

Ninety-five percent

of the serum gold is bound to albumin (Mascarehas et al.,
1972).

Gerber (1964) found that denatured albumin from the

exposure to GST resembles a denatured albumin formed in the ·
presence of reagents that prevent sulfhydryl disulfide interaction.

Albumin binding is most likely related to the phar-

macokinetics of gold.

The pharmacodynamic binding or inter -

action of gold is still to be answered.
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ii.

Collagen. - Adam et al.

(1965) found that

after 8 weeks of gold thiosulfate (0.2 mg/Kg-rat/weekly) an
in vivo staining of collagen occurred in which the collagen

~

~~

banding could be observed with the electron microscope. When
the thiosulfate is cleaved, the gold moiety hardens the collagen by forming new crosslinks as demonstrated by the swelling of collagen fibrils and the contraction relaxation time
(Adam and Kuhn, 1967).

The solubility of collagen and the

lathyritic effect of s-amino propionitrile were decreased
due to gold thiosulfate (Adam et al., 1967).

Bismuth, copper

and mercury compounds also cause intra-vital crosslinks
(Adam et al., 1968).

The concentrations used in these stu-

dies are much higher than those used clinically but local
concentrations of gold due to dying macrophages loaded with
aurosomes may have a hardening effect on the collagen of the
pannus.
iii.

Lysosomal enzymes. - The inhibition of

lysosomal enzymes was proposed by Persellin and Ziff (1966)
as a mechanism of action of gold sodium thiomalate.

High

concentrations of gold (mg/ml) were used to inhibit acid
phosphatase, S -glucoronidase and malic dehydrogenase.

Tis-

sue concentrations are 50 ug/g but the concentrations of
gold in lysosomes, i.e. aurosomes, are much higher (Ghadially,
1979), though most gold in the aurosomes is protein bound
(Lawson, 1980).
iv.

Compliment. - Schultz et al.

(1974) re-

ported the inactivation of Cl (compliment-classical pathway)
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with serum concentrations of gold.

A lack of serum gold

levels and therapeutic effect (Gerber et al., 1972) might
indicate Cl and Cl esterase inactivation as a secondary
rather than a primary mechanism of action of gold.
b.

Cell interaction.
i.

Neutrophils. - Mowat (1978)

found that neu-

trophil chemotaxis was inhibited in vitro by gold.

Both

non-RA patients and RA patients who gained clinical benefit
from gold therapy, responders, have neutrophils that showed
a gold induced, dose dependent, reduction in chemotaxis.
Nonresponders did not exhibit a good dose dependent reduction
compared to responders, suggesting that this assay may be
a good means to screen for responders and nonresponders to
chrysotherapy.

More specific blockers of neutrophil chemo-

taxis have not been shown to be effective anti-rheumatic
drugs.
ii.

Macrophages. - Jessop et al.

(1973) re-

ported the phagocytic activity of neutrophils and macrophages was increased in patients with RA.

Patients respond-

ing to chrysotherapy have suppressed phagocytic activity due
to GST whereas nonresponders did not.

Ugai et al.

(1979)

found the incubation of GST (25 ug/ml) with monocytes in
vitro caused a morphological change, aurosomes, and that the
phagocytic activity was decreased without significant effect
of viability or adherence.

The suppression of phagocytosis

by gold salts and prednisolone were qualitatively similar
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though quantitatively gold is less potent, has a slower onset of action and longer duration of action (Roberts et al.,
1973).

Even though both gold and steroids are used to treat

RA, steroids do not prevent the progression of the disease
(Harvey, 1975).
iii.

Lymphocytes. - GST, at pharmacologically

relevant concentrations, inhibited mitogen and antigen induced proliferation of T-lymphocytes (Lipsky and Ziff, 1977).
T-Lymphocytes previously stimulated with concanavalin A were
not inhibited by GST.

Monocytes reversed the inhibition but

preincubation of gold with monocytes interfered with the
functional capabilities of the monocytes.
The fact that organic gold therapy impinges on several
target systems involved in the generation of the rheumatoid
process may be a critical factor accounting for its tolerable
or acceptable therapeutic index.

An overwhelming effect on

any one of these critical functions would be associated with
unacceptable toxicity to the patient.

Thus, the proven

therapeutic benefit derived from chrysotherapy in the management of rheumatoid arthritis may be dependent on a spectrum of pharmacological effects expressed on the different
biological components contributing to the rheumatoid process.
4.

Other gold compounds.
Metallic gold is ineffective as an antirheumatic

drug.
1972).

Gold chloride is effective but too toxic (Freyberg,
The thio-gold compounds were originally used because
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of their solubility (Jaffe, 1977) and have since been found
to be more effective and less toxic than nonsulfur containing gold compounds (Freyberg, 1972).
a.

Gold thioalucose.
Gold thioglucose is used to treat RA.

In mice

and guinea pigs gold thioglucose accumulates in the ventromedial hypothalamus and causes obesity (Dalferes et al., 1975
and Chang and Persellin, 1968). Herman et al.

(1972) found

gold thioglucose added to mouse fibroblast cultures increased
anphagic vacuoles with lipid droplets.
b.

Auranofin.
A new gold compound, still in phase III clini-

cal trials, SK&F D39162, S-triethylphosphine gold 2,3,4,6
tetra-O-acetyl-1-thio-B-D-glucopyranoside, auranofin, can be
taken orally rather than the intramuscular injection required for GST.

Like GST, auranofin has been shown to be

efficacious in the adjuvant rat model (Walz et al., 1976)
and with RA patients (Finkelstein et al., 1976 and 1980).
GST was shown to inhibit lysosomal enzyme activity (Presellin
and Ziff, 1966 and Ennis et al., 1968) but not enzyme release
(Ennis et al., 1968 and Pepper et al., 1974).

Auranofin

blocks release of leukocytes lysosornal enzymes (DiMartino
and Walz, 1977 and Finkelstein et al., 1977).

DNA and pro-

tein synthesis in lymphocytes (Finkelstein et al., 1977) and
Hela cells (Simons et al., 1979) were inhibited by auranofin.
With lymphocytes, the transport mechanism was inhibited as
demonstrated by [ 3 H]-2-deoxy-D-glucose but, not with Hela
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cells.

Morphological changes with auranofin include aurosome

formation (Thomas and Ghadially, 1977) and surface blebbing
on Hela cells (Simon et al., 1979).

Thus, the spectrum of

auranofin effects reveals both similarities and differences
compared to GST.

It is not known if both GST and auranofin

have the same mechanism of action in RA.
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III.
A.

.METHODS

Materials
All chemicals used in this investigation were reagent

grade or better.

For cell culture:

Dulbecco's modified

eagles medium (D.ME), fetal calf serum (FCS), penicillin.

.

streptomycin, fungizone, trypsin and trypan blue were all
obtained from Grand Island Biological Co., Grand Island,
N.Y.

Tissue culture flask$,test tubes and pipets were from

Corning Glass Works, Corning, N.Y.
Schering Corp., Kenilworth, N.J.

Gentamycin was from
Ascorbate 6-aminopropio-

nitrile (BAPN) and ethylenediaminetetracetic acid (EDTA)
were all from Calbiochem, Los Angeles, Ca.

Isotope [

14

C]
3
proline (260 Ci/mole, 2-3 .( 3H]proline (25 Ci/mole) and ·[ H]
3

thymidine [ HJ TdR(542 Ci/mole) were all from New England
Nuclear, Boston, Ma.

.
'
TM
.
. 11 ation
Th e sc1nt1
coc k tai. 1 , Hy d remix,

was from Yorktown Research, Miami, Fl.

Enzymes used were:

ribonuclease (bovine pancrease, A grade, 65000 U/mg) from
Calbiochem, Los Angeles, Ca., pepsin (2500 U/mg) from Worthington Biochemical Corp., Freehold, N.J., and bacterial
collagenase (2600 U/mg) from Advance Biofacturers Corp.,
Lynbrook, N.Y.

For the nucleic acid assay DNA (calf thymus,

type I), RNA (yeast, type XI) and ethidium bromide were
all from Sigma Chemical Co., St. Louis, Mo.

Carboxymethyl

cellulose (CM-52) was from Whatman, Kent, England.

For
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polyacrylamide gel electrophoresis, electrophoretic grade:
sodium dodecylsulfate (SDS), acrylamide, N,N' methylenebisacrylamide (BIS), N,N,N',N'tetramethylenediamine (TEMED)
and ammonium peroxydisulfate were all Eastman Kodak Co.,
Rochester, N.Y.

Acetone (spectrometric grade) and B-mercap-

toethanol were both from Aldrich Chemical Co., Milwaukee, Ws.
The fluor 2-methoxy-2,4-diphneyl 3(2H)

furanone (MDPF) was

from Hoffman La Roche, Diagnostic Division, Nutley, N.J.
Glutaraldehyde for cell fixation was from Eastman Kodak Co.,
Rochester, N.Y.

Gold sodium thiomalate (GST) was from Merck,

Sharp & Dohme, West Point, Pa.

B.

Culture Method
Synovial tissues were obtained from patients with RA

who were undergoing reconstructive joint surgery at the
Roger Williams General Hospital, Providence, R. I.

Synovial

tissue identified as rheumatoid was obtained from patients
fulfilling the American Rheumatism Association criteria for
rheumatoid arthritis.

The rheumatoid patients had advance

erosive stages of the disease that required surgical intervention.

In all cases, histological examination of the ex-

cised tissue revealed chronic synovitis consistent with
rheumatoid arthritis.
The tissue obtained during surgery was dissected free
of any excess fat, capsular and cartilage tissue, and finely cut into approximately lmm

3

pieces; about fifteen tissue

pieces were placed in each 100 x 20 mm tissue culture dish.
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The cultures were incubated at 37° in the presence of 95% air
and 5% carbon dioxide.

The cells were grown in Dulbecco's

Modified Eagles (DME) medium containing 10% (v/v) heat denatured fetal calf serum (FCS) plus 100 units penicillin
and 100 ug streptomycin/ml medium or gentamicin sulfate (50
ug/ml medium) and Fungizone (2.5 ug/ml medium).

After one

or two weeks the cells could be seen migrating outwards from
the tissue pieces and after approximately four weeks the
cells became confluent and were subcultured into 75 cm
sue culture flasks.

2

tis-

To subculture (passage) the cells, the

medium and original tissue fragments were removed by suction
and the cell layer removed from the dish by incubation for
five minutes in isotonic phosphate buffered saline (PBS)
(ph 7.0) containing 0.1% trypsin 0.2 mg/ml glucose and 0.2
mg/ml ethylenediaminetetraacetic acid (EDTA) .

After detach-

ment, the cells were resuspended in fresh medium and replated.

Two weeks after the first passage the synovial cells

were subcultured again and this time replated at one-third
of their confluent density.

The cells were usually conflu-

ent again and subcultured after a further two-week period.
The cell medium was normally replaced with fresh media every
4-6 days.

All experiments were performed with cells during

second to fifth passages.

The cell cultures were tested

for and found to be free of mycoplasma contamination using
a fluorescent assay (Bioassay Systems, Cambridge, MA).
Gold sodium thiomalate (GST) was diluted in sterile
distilled water.
culture medium.

A 0.01 vol. of drug solution was added to
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C.

Cell Number Determinations
1.

Hemocytometer.
With the hemocytometer determinations, cells were

diluted with medium and both sides of a hemocytometer (American Optical) were filled.

The four corner squares and cen-

ter square from eacp side was counted.

To determine the

viability of the cells a 1:1 (v/v) of 0.04% trypan blue was
added to diluted cells which were then counted as described
above.

Dead cells retained the dye and appeared dark blue

under the microscope.
2.

Coulter counter.
For Coulter counter determinations, cells were di-

luted with filtered PBS and the total number of particles
in the channels calibrated from 10-60 microns diameters
were used for cell counts.

Mean cell size was determined

by multiplying the number of particles in each channel by
the mean particle size of that channel.

The product, the

total cell layer volume, was divided by the total number of
cell particles.

D.

DNA Assays
1.

Ethidium bromide.
The DNA content of the cell layer was assayed by a

modified method of Prasad et al.

(1972).

The cell suspen-

s±on was sonicated twice at 50 watts for 10 seconds.

A

0.1-0.5 ml aliquot of the cell sonicate was added to 10X75
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disposable test tubes.
0.5 ml with PBS.

The total volume was brought up to

An equal volume (0.5 ml) of 20 ug ethidium

bromide/ml PBS (pH 7.5) was added.

The fluorescence in the

test tubes was determined in an American Bowman spectrophotometer at an excitation of 360 nm and an emission of
590 nm.

The RNA was digested by adding 10 ul of 20 mg ribo-

nuclease H2 o then incubating at 50° for 30 min.

The fluor-

escence due to the RNA in the cells was found to be minimal
in the assay.
nated.

Therefore, the RNA digestion step was elimi-

DNA was dissolved in phosphate buffered saline (PBS)

.pH 7.5 and 1-5 ug/tube were used as standards.
2.

3
[ H]Thymidine

The rate of DNA synthesis was mea~ured by adding.
3
3
0.5 uCi[ H]thymidine( [ H1TdR)/ml medium 4 hr before harvesting the cell layer.

Cells were released from the dishes

using the trypsin solution described above and precipitated
twice in a 10% (v/v) trichloracetic acid (TCA) solution.
Precipitent was separated from supernate by 3000g centrifugation for 30 min.

The TCA pellet was dissolved in 1 ml

of 0.05 N NaOH, and radioactivity was determined in a
Packard Tricarb liquid scintillation counter.

E.

Gold Determination-Atomic Absorption
The amount of gold in the sonicated cell layer was de-

termined using a Perkin Elmer model 460 atomic absorption
spectrophotometer.

Gold sodium thiomalate (GST), 50% (w/w)
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gold was diluted with water as the standard.
range was from 5-50 uM.

The linear

The cell sonicates were diluted

with water and absorption measured at 242.8 nM.

A quanti-

tative increase in absorption was found by spiking the
biological samples with known quantitates of GST as an internal standard.

F.

Collagen and Noncollagen Protein Synthesis
Flasks of synovial cultures were incubated for 24 hrs

with D.ME medium containing 2,3[ 3 H]proline 10 mci/ml
propionitrile (BAPN) 100 ug/ml ascorbate 100. uM.

S -amino-

The medium

was removed and dialyzed exhaustively at 4° against O.lM
tris-HCl buffer pH 7.4.

The cell layers were trypsin re-

leased and cell number or DNA content determined as described
above.
3
3
The measurement of [ H]collagen and [ H]noncollagen

protein synthesis was determined by the collagenase digestible protein assay as described by Peterkof sky and Diegelman (1971) .

Bacterial collagenase was confirmed to be pro-

tease free by the failure of the enzyme solution to degrade
14 c-tryptophan-labeled Echerichia coli protein.
does not contain tryptophan.)

(Collagen

From the dialyzed medium a

0.1-0.5 ml aliquot, +100 units bacterial collagenase were
incubated for 3 hrs at 37°.

The incubation medium, 0.8 ml

total volume, contained 0.25 rnM CaC1 2 , 2.5 rnM NEM and 0.2M
Tris HCl pH 7.4.

At the end of the incubation, 0.1 ml 1%
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bovine serum albumin (BSA) and 0.1 ml TCA (50%) were added.
The precipitates and solutions were chilled at 4° for 1-24
hrs.

After centrifugation, 3000g for 30 min, the supernate

was removed and 0.1 ml BSA (1%) was added for a second precipitation. After a second centrifugation of 30 min at
3000g the supernates were placed in 10 ml of Hydromix™ and
radioactivity determined.
The percent collagen was calculated according to the
following formula:

% Collagen=

3

~~~~-:-~~~~~<C_P_M-=-[_H~}~p~r_o_l~i~n~e:........:i~n:........:c~o~l~l~a~g~e~n~)~X~l~0~0~~~~~~-

5. 4X(CPM [3H]proline in noncollagen)+(CPM[ 3H]proline in collagen)

'Where the

total protein equals the dialyzed medium CPM, the

collagen protein equals the CPM of supernate with collagenase minus the supernate CPM without collagenase and the noncollagenase protein equals the total protein minus collagen
protein.

When the pellets were analyzed total protein equals

CPM of pellet with collagenase and collagen protein equals
the total protein minus noncollagen protein.

The pellet

method is variable because the quantitation of collagen is
a small difference between two large numbers, as opposed to
the supernate method.

The above formula accounts for the 5.4

times greater amount of praline in collagen than in noncollagen protein.

G.

Medium Collagen Assay for Type I and III Collagen
1.

Extraction.
Cells in 75 cm flasks were incubated with 10 ml of
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fresh medium containing B-aminoproprionitrile (BAPN)
4
g/ml) and ascorbate (10- M).

(l0- 4

Ascorbate was added to the

flasks every day during the incubation period.

r14 c]pro-

3
line or 2,3[ H]proline (1 uCi/ml medium) was added 48 to 72
hrs before the medium was harvested.

Labeled praline in-

corporation in this system was found to be linear over a
72 hr period.

In the presence of BAPN to inhibit collagen

crosslinking and ascorbate to ensure hydroxylation, the
amount of radioactive collagen present in the cell layer
was below the limit of detection of the collagenase digestion assay (Kuttan et al., 1979).

In view of this, these

studies were conducted on collagen harvested only from the
medium; the cell layer was used for the cell proliferation
studies described above.

Medium protein was precipitated

by adding ammonium sulfate crystals to 45% saturation. After overnight incubation at 4°, the precipitate and solution
were centrifuged at 3000 g for 30 min.

The pellet (which

contained more than 95% of the nondialyzable hydroxyproline)
was dissolved in 1 ml of 0.5 M acetic acid and then dialyzed in the cold at 4° against 0.5 M acetic acid.

Pepsin

(100 ug/ml) was added to the dialysis bags to digest noncollagen protein and convert procollagen to collagen.
alysis was continued for another 2 days and the samples
were then lyophilized or dialyzed against .05M sodium

2.

Sample preparation for electrophoresis.
Samples were prepared for electrophoresis as

Di-
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described by Goldberg and Fuller (1978) by dissolving them
in 0.05 M sodium phosphate (pH 7.2) containing 0.2% sodium
dodecylsulfate (SDS) and 10% sucrose.

The pH was adjusted

with sodium hydroxide and the proteins were made fluorescent by the addition (with mixing) of 0.2 vol. of a 2-4 mg
MDPF*/ml acetone solution. Disulfide bonds of type III
collagen were reduced (R) by heating the alkaline samples
(pH

=

10-11) at 56° for 15 min.

Nonreduced (NR) samples

were prepared by returning the fluorescent samples to neutrality (pH
3.

=

7-8) with hydrochloric acid before heating.

Electrophoresis procedure (MDPF-SDS-PAGE)
Samples were electrophoresed according to the pro-

cedure of Neville (1971) • This is a discontinuous Trisborate buffer system with SDS only in the upper buffer and
sample preparation buffer.

The upper buffer is 0.5% Tris,

0.25% boric acid and 0.1% SDS.
Tris-HCl pH 8.5.

The lower buffer is 0.15M

The gels (5mm x 55mm) used to separate

collagen components were 6% acrylamide, 1% N,N'-methylenebisacrylamide (BIS), 0.05% ammonium peroxy-disulfate, 0.1%
N,N,N',N'-tetramethylendiamine (TEMED) and 0.15M Tris
HCl pH 8.5.

The stacking gels were 4% acrylamide, 3.3%

Bis, 0.1% TEMED, 0.05% ammonium peroxydisulfate and 0.04M
Tris-HCl pH 6.1.

The samples were electrophoresed (Buchler

Instruments) into the stacking gels (0.5-1.0 h), at 0.2
mAmps per tube; the current was increased to 1.0 mAmp per

* MDPF=2-rnethoxy-2,4-diphenyl-3-(2H)-furanone.
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tube for electrophoresis in the running gel for 2.5-3.5 at
room temperature.
4.

Quantitation of collagen types I and III.
a.

Scanning procedure.
The quantitation of fluorescence in the gels

was determined as described by Goldberg and Fuller (1978).
After electrophoresis the gel tubes (containing gels) were
either sealed with parafilm and stored at 4°C or placed in
the gel tube holder of the Gilford linear transport gel
scanner.

Fluorescence scanning was done with a Gilford 250

spectrophotometer equipped with a Corning 840 recorder, a
Gilford 2520 gel scanner, and the Gilford 2515 fluorescence
gel accessory.

The Model 2515 has a light source and ex-

citation filter to provide an excitation energy at 390 nm
at right angles to the optical path of the spectrophotometer;
the emission filter placed between the gel tube and the
photometer allows emission light to pass through at 480 nm.
The Model 2515 also includes a signal converter which performs an antilog conversion of the photometer signal. Therefore, · the recorded signal is proportional to the light received.

To standardize measurements, standard quinine so-

lutions in gel tubes sealed with parafilm were placed in
the linear transport.

By adjusting the recorder span con-

trol the pen of the recorder was set to record the output
of the spectrophotometer in accord with the following equation:
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=

RFI

log-l (2 - Abs.)

where RFI is the relative fluorescent intensity measured by
the percentage of pen movement.

Abs is the absorbance units

read from the Gilford spectrophotometer Model 250.
b.

Fluorescence of band.
The gels were scanned at 2 cm/min with a

chart speed of 4 cm/min.

The areas under the peaks were

quantitated using a Numonic Electronic Planimeter Model
210-117, with peak area given in square centimeters.

(Full-

scale pen deflection on the Corning recorder was 25 cm.)
The fluorescence in the gels was quantitated by the following equation:
2

RFI x mm

= area (cm ) x gel scan rate (cm/min) x 10 (mm/cm)

scale factor (cm/RFI) x chart speed (cm/min)

where RFI x mm is the relative fluorescent intensity corrected for band width on the gel.

Increasing the instrument

scale factor results in a linear increase in sensitivity of
the recorder thereby increasing pen deflection (cm) per
unit of RFI.

The area under the peaks recorded from fluoro-

metric scanning of MDPF-labeled

a. l (I), a. 2, and

·a.1 (III)

was linear from 10- 5 to 10-a g.

The standard curves for

the three a. chains were similar. The results from nonreplicate determinations had an SE of + 6.

Using a standard

curve from purified a. l(I) calf skin collagen, the fluorescent area (RFI X mm) of synovial cell medium MDPF-labeled
collagen was converted to amount of collagen

a.

chains.
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c.

Radioactivity of bands.
The radioactivity in the bands corresponding

to

chains was determined by dissolving 5 mm slices in 0.2

ml hydrogen peroxide and then heating at 60° for 4 hr or at

37° overnight.

Ten milliliters Hydromix™ were added to the

vials,. and the radioactivity was determined in a Packard liquid scintillation counter.
T~e ~ercentages

of type I and type III collagen in SDS

polyacrylamide gels were calculated from the following formulas:
=

3
x 100
a1 (R)
a2 (R) + 1

% Type III =

a1 (R}
a1 (NR)
a2 (R)
a2 (NR)
al (R)
a2 (R) + 1

% Type I

x 100

where al (NR) and a2 (NR) are CPM found in the gel slices or
fluorescence found in the peaks at the al and a2 chain positions, respectively, after electrophoresis of a nonreduced
sample; and where al(R) and a2(R) are the CPM found in the
gel slices or fluorescence found in the peaks at the al and
a2 chain positions, respectively, after electrophoresis of
a reduced sample.

H.

Carboxymethyl Cellulose Chromatography (CMC) of
Collagen
Collagen [ 14 c]labeled samples were analyzed by car-

boxymethyl cellulose chromatography, using the procedure
described by Miller (1976).

A 1.8 x 10 cm column (Pharmacia,
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Uppsala, Sweden) was filled with carboxymethyl cellulose
equilibrated in 0.06 M sodium acetate buffer (pH 4.8) and
maintained at 42°.

The

14

C-labeled collagen samples, con-

taining 2-4 mg of type I and type III calf skin collagen
(prepared as described previously (Fujii and Kuhn, 1975)) as
carrier, were denatured by heating at 56° for 30 min in the
presence of 10 M urea.

The samples were reduced by the ad-

dition of 1% (v/v) B-mercaptoethanol and applied to the
column.

The collagen a chain components were eluted from

the column using a linear salt gradient; the starting buffer
consisted of 200 ml of 0.06 M sodium acetate buffer (pH 4.8),
and the final buffer consisted of 200 ml of starting buffer
containing 0.1 M sodium chloride.

The eluant was collected

in 12-ml fractions; 1 ml of each fraction was mixed with 10
ml Hydromix™ and the radioactivity was counted.

The per-

centages of type I and type III 14 c-labeled collagen were
calculated from the radioactivity eluted in the peaks that
correspond to al(l), al(III) and a2 chains.

The al(I),

al (III) and a2 :_Jpeaks were confirmed by their electrophoretic
migration on SDS-polyacrylamide gels.

I.

Purification of Type I and III Collagen Standards
The procedure adopted for the purification of collagen

was that of Fujii and Kuhn (1975) .

Skin from a newborn

calf was extracted in cold 0.05M Tris-HCl pH 7.5, lM NaCl
for several days.

The insoluble material was extracted in

47

the cold, with 10% acetic acid for several more days.
remaining skin and extract were both lyopholized.

The

Freeze-

dried skin, lOOg, was rehydrated in 25 1 of 0.1% acetic acid
pH 2.0 (adjusted with HCl), 25.0 g pepsin was added slowly
with stirring, after 24 h 17.5 g pepsin was added for a further 24 h digestion at room temperature.
The solubilized material was filtered through sintered
glass wool.

Sodium chloride crystals were added to the fil-

trate to give a final concentration of 0.9M sodium chloride;
the mixture was allowed to stand overnight at 4° C.

The

collagen that precipitated out was collected by continuous
centrifugation at 15,000Xg for 1 hr.

The pellet was resus-

pended in 0.5M Tris-HCl pH 7.5, to inactivate the pepsin for
four days, and then centrifuged at 35,000Xg for 1 hr.

The

supernatant was lyopholized.
Differential salt precipitation (DSP) was performed
to harvest the pepsin released Type I and Type III collagen;
30g of the freeze-dried supernatant was dissolved in 10 1 of
.05M Tris-HCl pH 7.5, lM sodium chloride.

Sodium chloride-

(4M) was added to make a final salt solution of l.7M sodium
chloride.

The volume of 4M NaCl added was determined by the

following equation:
C1. V.1 + CV
a a

=

Cf(V 1. +V a )

where Ci is the initial salt concentration (lM), Vi is the
initial volume (10 1), Ca is the added concentration of salt
(4M) and Cf is the final desired salt concentration (l.7M).
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The equation is . solved for V which is the volume of 4M sodia
um chloride added. The solution was allowed to stand for
24 hr at 4° and then centrifuged at 35,000Xg for2 hr.
precipitant was washed by

centr~fugation

Tris-HCl pH 7.5, l.7M NaCl.

The

three times in 0.5 M

It was resuspended in 1% acetic

acid and dialyzed against 1% acetic acid, and then centrifuged at 55,000Xg for 1 hr.

The supernatant was lyopholized

and characterized as type III collagen by further purification gel electrophoresis, and cyanogen bromide peptide mapping.

The salt concentration of the supernatant was then

increased as described previously, again this time from l.7M
sodium chloride to 2.5M sodium chloride with 4M sodium chloride.

The resulting precipitant was allowed to settle for 24

hr and harvested by centrifugation at 35,000Xg for 2 hr. The
pellet was resuspended in 1% acetic acid dialyzed against 1%
acetic acid and then centrifuged at 55,000Xg 1 hr.
supernatant yielded lOg of Type I collagen.

The

The collagen

was characterized by further purification, gel electrophoresis, and cyanogen bromide peptide mapping.

J.

Phase Contrast Photomicrographs
Phase contrast photomicrographs of cells in growing

monolayers were obtained using an American Optical inverted
microscope equipped with Expo star automatic shutter control
format

35mm (2.8X), ASA 16 and Reciprocity B.

used was Kodak high contrast copy film HC135-36.

The film
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K.

Electron Microscope (EM)
Three types of preparations were used to examine synovial

cells and tissue with the EM.

Osmium stained preparations

which stained membranes were used to examine ultrastructures
and for X-ray probe analysis.
1.

.Nonosmium procedure.
For the n.onosmium treated preparation, 1 cells were

fixed in the culture dishes with 1.6% (v/v) gluteraldehydePBS pH 7.3 for 30 min at 4°.

The cell layers were scraped

off with rubber policemen, transferred to a 15 ml conical
centrifuge tube and centrifuged at 2,000 RPM for 5 min. The
pellets were resuspended in 200 ul of PBS pH 7.3 and transf erred to a 400 ul microcentrifuge tube (Eppendorf) .

The

pellet was washed three times by centrifugation, 8000 RPM
for 5 min.

A drop of PBS, approximately half the volume of

the pellet, was added after the last wash to maintain moisture.

The samples were dehydrated with alcohol and epon em-

bedded.

Sections, using a Sorvall MT-1, were stained with

uranyl acetate and lead acetate and examined with a Siemens
101-TEM.
2.

Osmium procedure.
For osmium fixed cells,

2

the cells were first fixed

1 The EM work was conducted by Dr. Elizabeth LaDuc at
Institut de Rechurches sur le Cancer, Boite #8, 9480 Villejif, France.
2

The EM work was conducted by Grant Jolly at the Roger
Williams General Hospital, Department of Pathology, Providence,
Rhode Island.

so
with 1.5% gluteraldehyde in O.lM sodium cacodylate buffer and
then post fixed in 1% osmium tetroxide in O.lM sodium cacodylate buffer.

The cell pellet was embedded in epon and 1 mic-

ron sections were stained with toladine blue.

Ultra-thin

sections (60 nM) were cut using a LKB ultratome III then
stained with uranyl acetate and lead citrate.

Representative

photomicrographs were taken with an RCA EMU-4C.
3.

X-ray probe analysis.
For X-ray probe analysis

3

cells were fixed in 2%

gluteraldehyde, 2% parafermaldehyde-Cacodylic acid buffer.
An energy level of 75 KeV in a Hatachi HS00-1 was used to
obtain the L and M shells for gold.

L.

Statistics
Linear regression lines for plots were drawn using a

Hewlett Packard XY plotter model 9862A connected to a
Hewlett Packard model 10 calculator.

A Texas Instrument

SR-52 programmable calculator was used for statistical analysis.
L:

1.

Mean:

x

=

x.1
n

i=l, 2, ... , n

3 The X-ray probe analysis was conducted by Philip McGrath
and John Ewell at the Bureau of Biologics, Division of Pathology, Food and Drug Administration, Building 29, National
Institute of Health, Bethesda, Maryland.
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where n

=

sample size ,

X.l.

=

value for each sample

2

I: (X. 2.

Standard error:

3.

Linear regression:

Slope:

b.

Intercept:

4.

A

b

l.

=

n(n-1)
"'

......

Y = b

0

=

1

X + e

(Y.-Y)
l.

A

Y - b

1

X

r

Correlation coefficient

=

rcx.-x)
. l.
x.l. -X)

2

(Y.-Y)

2

l.

f(Y. -Y)

2

l.

Student t test
t(n-2)

5.

+ b

0

[cx.-x)
l.

"'b 1 =

a.

c.

S.E.

X)

=

One way analysis of variance (ANOVA) with completely

randomized design.
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a.

Source

ANOVA TABLE
Sum of
Squares

Degrees of
Freedom

Treatment

K-1

Error

n-K

K

~

·2
T·J n

Kn

2

l!Y.l. J.
Total

n-1

i=l,2, ... ,N

b.

Mean
Squares
T ••

2

/n

MS Tr

F

MSTr/MSE

K

- L

km
!!Y .. 2 - T •• 2 /n
l. J

MSE
F

k-1, n - K, 1-o(

j=l,2, ... ,K

Post Hoc ANOVA was Duncan's multiple range test

p=2 ... K
6.

AP< 0.05 was considered significant.
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IV.
A.

EXPERIMENTAL RESULTS

Morphology
1.

Light microscope.
When synovial cells were examined by phase contrast

microscopy, perinuclear vacuoles were observed in the synovial cells which had gold in the medium.

In order to determine

th.e time and concentration dependence on vacuole formation,
synovial cells were grown in medium containing 250, 125, 100,
60, 50, 30, 25, 15, 10, and 7.5 uM gold sodium thiornalate
(GST) containing medium.

Cells were observed daily and re-

presentive photomicrographs were taken (Fig. 1).

The onset

of vacuole formation occurred between 2-3 days for concentrations between 250-lOOuM.

The number and the size of the

vacuoles increased with time of incubation to a maximum observed at 5-7 days when most of the cells had vacuoles.
There was also a decrease in the observed number of cells in
the cultures.

If the gold (250-lOOuM) was removed from the

medium the observed number of cells remained the same and
the cultures did not grow to confluency even after subculturing.

The number of cells retaining trypan blue did not in-

crease due to the GST exposure (Table 1) .
Vacuole formation was found at 60 and 50uM GST after
5-7 days and an increased number and size of vacuoles was
observed over the following week.

The size and number of

·Fjg. , 1.

Phase contrast photographs of synovial cells exposed
to GST ( 200X) .
(a) control (b) 30 uM GST for 14 days
(c) 125 uM GST for 4 days (d) 125 uM for 7 days .

V1

..,..
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TABLE l
EFFECT OF GOLD SODIUM THIOMALATE (GSTl_ ON CELL VIABILITY

.
b
Cell Counted
per flask -

GS Ta
(uM)

157" + 20

0
10

119 +

30

48' +

a

7 (_3)
6

c

9 8. 8 + 0.5
98.3 + 1.2
-

(4 ye

95. 3- + 1.4

-

f
31 (23-39)
- .

100

a

C4l

Percent
Viable

89

(_83-95)

Cells were exposed to GST for one or two weeks.

bCells were counted with a hemocytometer.
cViability was determined by trptan blue exclusion.
dMean + S.E.
e

Cn =

number of flasks)

p < 0.01.

fMean (range) for two flasks.

from two experiments.

vacuoles after two weeks of 60 and SOuM GST were less than
those obtained for lOOuM GST for one week.

Only a minimal

amount of vacuole formation was obtained from the 30 and 25
uM concentrations after two weeks of exposure.

Synovial

cells did not develop vacuoles after one month exposure to
the lower concentrations.
Exposure of the synovial cells for one week to lOOuM of
mercury, lead, cadmium, silver, copper, zinc, sodium thiomalate and gold chloride did not reveal the characteristic
vacuole formation observed with gold sodium thiomalate (GST).
2.

Electron microscope (EM).
In order to determine if the vacuoles contained

gold, cells were fixed with gluteradlehyde at various times
after exposure to GST.

In cultures (lOOuM for one week) that

presented numerous vacuoles by phase contrast microscopy,
many such vacuoles were found with electron dense material
by EM (Fig. 2).

At the low GST concentration (lOuM for one

week) that did not have any evident vacuoles by light microscopy, only a few electron dense vacuoles were found after
examining many cells.

X-ray probe analyses confirmed that

the electron dense material in the membrane bound vesicles
is gold.
a.

In vivo and in vitro aurosomes.
Oryshak and Ghadially (1976) named the membrane

bound vesicles of gold found in cells aurosomes. Fig. 3 is
a comparison of aurosomes observed both in vivo and in vitro.
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Fig . 2 .

EM photograph of aurosome and X-ray probe ana lysi s.
Cells were stained with osmium . A portion of the nucleus is in the upper right-hand
corner . Beneath the nucleus is a golgi apparatus .
Three longitudina l sections of mitochondrias are
to the left of the golgi . Electron dense areas i n
the membrane bound vesicles had an X-ray probe
analysis for gold , lower left. The bars in the center are the theoretical lines for the L&M shell
of gold. Beneath the bars is the scan of an elec tron dense area .
The large peak in the center is
from the copper in the copper grid .
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Fig . 3 .

In vivo and

~n

Vitro aurosornes .

Synovial tissue

Ta and b ) anc:r-synovial cells (c a nd d) were not
osmium stained .
(a) In the lower right-hand cor ner is collagen ; in the upper right-hand corner
is the nucleus .
The many electron dense areas
to the left of the nucleus are go ld aggregate s
in a lysosome .
(b) Aurosome to the right of
the nucleus.
(c) and (d) Electron dense gold
a9gregates in the lysosomes of synovial cells
in culture .
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The patient donor of this section had been receiving gold
therapy for 2 years and had discontinued gold therapy for
several months before synovectomy.

The aurosome structures

are nearly identical in both the sections of synovial tissue
and in the gold induced aurosome in the cultured synovial
cell.
b.

Genes·is of the aurosome in culture.
Fig. 4 is· a proposed sequence in the develop"""

ment of an auros.ome.

First the gold is precipitated with

proteins. to form an electron dense aggregate ·o utside the
cell.
Th~

The gold aggregates are phagocytosed or pinocytosed.

protenous core is broken down Cpossibly by enzymes) and

plate-like structures and small round electron spheres or
rods in cross-sections :Oecome numerous.

Eventually the pro-

posed protenous core is diss-ol ve.d leaving just aggregates
of lamellae structures-.

c.

Nuclear change.
The expos·ure of cultured synovial cells to

GST (_125

uMI results in a nuclear change.

Chromatin clump-

ing near out not attached to the nuclear envelope. occurred
in s-ome nuclei (_Fig. Sf.

This was not found as consistently

as aurosorne formation. An anti-malarial drug quinaqrine can
cause s·imilar nuclear changes (LaDuc ·et ·
preparation) •
drugs

us~d

al~

.1

manuscript in

Anti-malarial drugs are also second-line

in RA.
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Fig . 4 .

Genesis of aurosomes . Cells were not osmium
stained .
(a) An electron dense aggregate is
pinocytosed .
(b) Many small particles break
off the electron dense material in a lysosome.
(c) Lamellae structures form in the lysosome .
(d) The protein core is dissolved .

'

-Fig . 5 .

··--- GST induce d nucleus change . The cells were stained
with osmium.
(a)
A control synovial cell nucleus
with two nucleoli .
(b)
A nucleus in a synovial cell
that was exposed to 125 uM GST for one week . One
nucleoli is in the nucleus with many electron dense
areas (clumped chromatin) near the nuclear membrane.

O'\
f-'
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B.

Biochemistry
1.

Proliferation.
Because GST has· been shown to prevent the progression

of the pannus (Sigler et al., 1974} in RA, the effect of GST
on the proliferation of synovial cell cultures was studied.
Clinically, tfie effect of gold

i~

persistent but not permanent,

therefore, the reversibility of GST effects on synovial cells
was also investigated.
a.

Cell number and size.
Fig. 6 demonstrates tfie effect of two GST con-

centrations on the synovial cell growth curve.

Cells were

plated on day zero with 10,000 cells and on day one 25uM or
250uM GST were added to the medium.

The normal doubling

time of these cells· is approximately 5 days.

There was no

significant difference in cell number after five days of GST
exposure.

After 10 days there was a suppression in cell num-

ber with both concentrations·.

After an initial doubling of

the culture growing with the 250uM GST, there was a continuous
decrease in the number of cells.

When the 250uM GST was re-

moved from the medium after 10 days of exposure, there was
no change in cell number after 6 days.

With the 25uM GST

containing cultures the cell number increased but at a slower
rate than the controls.
GST did not cause a significant decrease in cell viability (Table 1) but did s·ignificantly decrease cell number.
This can be explained on the basis of cell death which causes
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Fig. 6. Effect of gold sodium thiomalate
(G§T) on cell
growth curve. Cells (105) were plated in 25cm flask on
day zero. The medium was changed on day 1 with the addition
of GST to the gold treated flask.
GST was added after medium
changes on days 6 and 12. Each point represents the mean of
three flasks. Cells were counted using a hemocytometer.
•
Control, (.) 2Sua
GST, (A) 250uM GST and (A) GST
was not added after medium change.
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the cells to detach from the flask.

The gold treated cells

appeared larger than the nongold exposed cells in the hemocytometer.

In order to determine if gold caused a change in

cell size, treated cells were counted using a Coulter counter.

Fig. 7a shows the size and number of particles counted

in the channels of the Coulter counter.

In the presence of

GST, there was a shift to larger particles and a decrease in
the number of particles.
counting orifice.

No clumping was observed at the

The increase in small particles may be due

to the presence of gold protein aggregates.

This increase in

cell size and a decrease in cell number was concentration dependent between 7.5-125W.1 GST (Fig. 7b).

These concentrations

are equivalent to the gold concentrations observed clinicly
in serum and synovial tissue of patients, respectively (Gerber,
1972; Grahame et al., 1974 and Gottlieb et al., 1972).
In order to determine if the increase in cell size was
related to the decrease in proliferation, synovial cells were
incubated with latex beads (O.Su) and/or GST for 14 days
(Table 2) .

The latex beads increased the cell size but did

3
3
not decrease [ H]thymidine ( [ H]TdR) incorporation.

GST and

3
GST plus latex beads decreased [ H]TdR incorporation.

A mix-

ture of latex beads and GST caused a decrease of cell size
when compared to the cell size of cells exposed to
alone.

Ugai et al.

(1979)

reported GST

inhi~its

la~ex

beads

phagocytosis.

This would account for the decrease in cell volume with the
mixture of latex beads and GST.
b.

DNA content and rate of synthesis.
In order to further characterize the antipro-

liferati ve effect of GST on synovial cells, the dose (time and
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TABLE

2

EFFECT OF LATEX BEADS AND GOLD SODIUM THIOMALATE (GST)
ON PROLIFERATION AND CELL SIZE

GST (uM) a
a
Latex
Beads
b
(dilution)

a

30

0
( 3 HJ TdRc

Cell size

d

3
( H]TdR

60

3
Cell size ( H]Tdr

Cell size
g

13.31+1.2e

5. 97+0 .13

2.0

8 . oof

1:10

11.6

9.17

1.6

8.70

0.8

7.18

1:20

15.9

9.20

2.0

8.20

1.0

7.27

Cells were exposed to GST and latex beads for 14 days.

bLatex beads (O.Su) were diluted in sterile water and then a 1% (v/v) was
added to the culture medium.
3
3
c r3Hlthymidine([ H]TdR) was the CPM X 10- incorporated into TCA
precipitable material.
d

. ·3
-3
Cell size was the mean volume, µ XlO
as determined by Coulter counter.

e

Control, mean + S.E. for three flasks.

fDuplicate determination from one flask.
gCulture lost.
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concentration) dependent effect of GST on DNA synthesis and
accumulation in culture synovial cells were measured.

Fig.

8a shows the effect of a high (lOOuM) and low (lOuM) drug
concentration on a DNA growth curve.

The high and low drug

concentration inhibited the DNA growth curve in a similar
manner as found with the cell growth curve (Fig. 6).

Removal

of GST from the medium resulted in only a partial recovery in
DNA accumulation at the high drug (lOOuM GST) concentration
and a complete · recovery at the low (lOuM GST) concentration.
After one month without lOOuM GST in the medium, the culture
did not grow to· confluency. Fig. 8b shows the concentration
dependent inhibition of GST on DNA content of flasks after
5, 15 and 20 days.

The curves shift to the left with increas-

ing exposure time again demonstrating that dose is time and
concentration dependent.
To confirm the ability of synovial cell proliferation
to resume normal division rate after removal of lOuM GST from
the medium,but not lOOuM GST,the dose dependent effect of GST
3
treatment on [ H]TdR was investigated.

The inhibition of

3
[ H]TdR was concentration dependent (Fig. 9b).

Fig. 9a shows

that the removal of lOuM GST resulted in a return to the control levels of DNA synthesis.

The removal of the high (lOOuM)

drug concentration illustrates a partial recovery, but the
continued downward trend indicates incomplete recovery.

The

inhibition of DNA synthesis preceded the inhibition of DNA
accumulation (Figs. 8a, 9a) which preceded synthesis (Fig. 10).
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2.

Protein synthesis.
Fig. lOa shows the relative time course for inhibi-

tion of protein synthesis.

At lOOuM GST the 50% inhibition

for DNA synthesis and protein synthesis was 25 and 9 days, respectively. The delay of onset of significant inhibition was
also longer for protein synthesis

(after 5 days) than DNA

synthesis (after 2 days).
a.

Noncollagen protein and collagen synthesis.
Fig. lOb shows the concentration dependent inhibi-

tion of collagen and noncollagen protein synthesis.

Because a

limited number of drug concentrations over a narrow range
were used to characterize the inhibition curve a probit transfermation was used to examine the correlation (r >0.95) between
drug effect and concentration.

Collagen synthesis was in-

hibited at each concentration more than noncollagen synthesis
(Fig. 10).

Fig. llc shows that there is a concentration de-

pendent inhibition of the percentage of collagen synthesized
with exposure to increasing GST concentrations.
Both proliferation and protein synthesis were inhibited
by GST, but the inhibition of proliferation preceded the inhibition of protein synthesis.

The dose dependent effect of

GST on collagen per cell and per DNA was biphasic (Fig. 11)
with first an increase in the amount of protein synthesized
per cell up to 30uM and a decrease to below control levels
at higher doses.

Using lOOuM GST, a time dependent increase

in protein per cell was found but this increase was not found
with protein per unit of DNA (Fig. lla).

However, an increase
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in protein synthesized per DNA content was found at 30uM GST
after 15-20 days of exposures (Fig. 11).

This discrepancy is

explained on the basis of the higher DNA content per cell
with increasing GST concentrations (Fig. 12).

The increased

ethidium bromide-DNA fluorescence is not due to GST in the
sample because the addition of GST to cell sonicates did not
increase fluorescence in this assay. When cell proliferation
was arrested by removal of the fetal calf serum (FCS) from
the medium, an increase in DNA content per cell was also
found.

Thus, increases in cell size and DNA content per cell

are most likely consequences of proliferation inhibition
(Greenberg et al., 1977 and Cristofolo and Kritchevsky, 1969).
Because the anti-proliferative effect of GST is dose dependent for both cell number and DNA, both were used to express
the cellularity of the culture though cell number is the more
conservative estimate of the two.

Therefore, the increase

in collagen and noncollagen protein synthesis is more dramatic per cell number than per microgram DNA.
b.

Collagen types.

i.

Electrophoresis. - Fig. 13 is a photograph

of a SDS-polyacrylarnide gel containing purified types I and
III calf skin collagen standards. Beneath the gel is a densiometric scan of the Coomassie blue stained proteins.

With

Coomassie blue, reduced a l(III) migrates a little slower
than a l(I) using the Neville (1971) gel system.
labelled chains the reduced

a l(III) and

With MDPF

a l(I) migrate to-

gether (Goldberg and Fuller, 1978) . Because BAPN is used with
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the cell culture system the dimers,

S 11 and Sl2, are not

found in the medium extracts of the cell culture s y stem. Type
III collagen is held together as a trimer,

y ,

and possibly

higher molecular weight forms by disulfide bonds.

The reduc-

tion of the disulfide bonds removes the y peak and causes a
concomitant increase in the a l peaks in extracted synovial
cell medium collagen (Fig. 14).

The peaks remaining at the

top of the gel are the interfaces of the stacking and running gels.

The fluorescence observed between the a and y

peaks did not contain radioactivity and was not found consistently.
The fluorescence is the amount accumulated for 5 days;
the radioactivity reflects the rate of synthesis for the last
2 days.

After 15 days of exposure to GST (7.5-30uM) a dose

dependent increase in collagens synthesized per cell was
found using the MDPF-SDS-PAGE separation procedure (Fig. 16).
This increase in collagen was predominantly type I collagen.
The increase in collagen content, by fluorescence, and the
rate of synthesis by the incorporation of radioactivity, were
14
similar, indicating that GST was not effecting c cJ proline
transport. Becausethe number of cells and percent of collagen
both decrease at high GST concentrations, not enough collagen
was extracted to quantitate collagen types at concentrations
above 30uM GST.
ii.

Chromatography. - Fig. 16 is the CMC chroma-

tograph obtained from synovial cell medium. The arrows represent the peaks of purified types I and III calf skin
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Fig. 16. Carboxy methyl cellulose chromatography (CMC) of
Qedium collagen extracts from control and GST exposed
synovial cells. ( e) control and ( 0) 7. 5 u..1-1 GST for 15
days.
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a chains used as standards.

The medium collagen was obtained

from two pooled cultures exposed to 7.5uM GST for 15 days or
from two pooled control flasks.
and

The small peak between a l(III)

a 2 was not seen with the 15uM GST exposed cultures.

The

effect of GST on collagen types as quantitated using fluorescence or radioactivity after separation by SDS-PAGE is compared to the results obtained when the radioactive samples
were separated by CMC chromatography (Table 3) .

SDS-PAGE sep-

arates the collagens by molecular weight with type III collagen being the increase in the a 1 position after reduction.
CMC separates by ionic charge with
tive than

a 1 (III) being more posi-

a l (I) and less positive than the a 2 chain of

type I collagen.

GST (7.5-30uM) significantly (P < 0.05) de-

creased the percent type III collagen synthesized by about
50%.

This decrease was not found to be dose dependent.

The

estimation of the portion of type III was greater when separated by CMC than SDS-PAGE but the decrease in percent type
III collagen is still evident by both separation techniques.
(Parrott et al., 1980) using rheumatoid arthritis, osteoarthritic and normal synovial cell lines found the estimation of percent type III collagen was greater by CMC than
SDS-PAGE.

These estimates obtained with t he two procedures

were significantly correlated (P < 0.01).
3.

Reversibility.
In order to further characterize the reversibility

of the effect produced by GST, the gold content of cell
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TABLE 3
EFFECT OF GOLD SODIUM THIOMALATE(GST)ON THE PERCENT OF
TYPE III COLLAGEN SYNTHESIZED BY SYNOVIAL CELLS

GST a

Electrophoresis(MDPF-SDS-PAGE)

Chromatography(CMC)
CPM

UM

CP~

0

32+6c

31+3

39d

7.5

13+le

10+3e

26

15

9+3e

8+3e

21

30

13+3e

20+2e

F390
480

f

aCells were preincubated with GST for 15 days. Fresh meditml without
GST but continuing BAPN and ascorbate was then added; the medium
collagen was harvested 5 days later.
b [ 14 c ]praline was added 2 days before the medium was harvested.
cMean + S.E. from triplicate flasks.
dSingle determination from two pooled flasks.
e
f

p

< 0. 05.

Insufficient collagen for quantitation.
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layer sonicates was determined by atomic absorption spectroscopy.

Fig. 17 shows that GST caused a dose dependent ac-

cumulation of gold associated with the trypsin released and
sonicated cell layers.

These cell layers were washed once

with PBS and once with 0.1% trypsin PBS pH 7.3, thus, the
gold detected with the cell layer is in and possibly on the
surface of cells.

The deposition of gold in the cell layers

has a lag time of a day and is inversely related to the inhibition of DNA synthesis (Fig. 17a).

The relationship of

medium concentration of GST to gold in the cell layer is log
linear (Fig. 17b).

When the cell layer volume was estimated

(by Coulter counter) there was approximately a 1000 times
greater concentration in or on the cells than in the medium.
Table 4 shows that the removal of gold from the medium
causes a decrease in gold associated with the cell layer but
that complete removal is not achieved after 14 days.

Table

5 shows the recovery of some biochemical parameters after
the removal of GST from the medium.

The recovery of the

biochemical parameters was not complete but neither was the
removal of GST from the cell layers.

The increase in gold

content per unit of DNA from experiments 1-3 was linearly
related to the decrease in the percent of control of DNA
content (slope = -1. 6, intercept = 79, r = 0. 64, p < 0. 01
and n = 17 flasks); total protein

synth~sized

(slope= -1.3,

intercept 72, r = 0.61 and n = 17); percent collagen (slope
= -0.93, intercept= 76, r = 0.57, p <0.01 and n = 17). The
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Fig. 17. Dose dependent accumulation of gold with the cell
layer after exposure of synovial cells to gold sodium
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(a) Time course for
gold deposition ( e) in or on the cells; ( •) inhibition
of DNA synthesis; (b) concentration dependent accumulation
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TABLE 4
QUANTITATION OF GOLD ASSOCIATED WITH SYNOVIAL AND SKIN CELL LAYERS
AFTER EXPOSURES TO GOLD SODIUM THIOMALATE (GST) CONTAINING MEDIUM

Cell
Line

GST
(uM)

RA-23c (2)d
(2)
(2)
( 2)

10/10
10/01•
30/30
30/0

Days with
GST in
Medium

a

Days without
GST in
Medium

17
9
17
9

0
8
0
8

b
Moles gold
g DNA

EXP 1

Xl0

Molecules gold

12

2.0
e
1.2(0.9- 1.5)
40 ( 35-44)
18 (11-26)

Xl0- 9

Cell

17
8(7-9)
400(180-610)
10 (10-11)

EXP 2
RA~l5

(2t3)
C2t3)

10/10
100/0

10(2)c+l9(3)
10 ( 2)

0
14 (3)

f

0.45(0.43-0 . 46)
12.0
EXP 3
-

RA-16 (2)
(3)
(.2)
( 3)

PY~Oh (2)
( 3)

lOCg
lOL
lOOC
lOOL

14
20
10
12

0
0
4
8

0.8
0.8
38.6
4.7

-EXP
30C
30L

5
5

0
0

4
44
470

10.3
44.1

aGold was determined by atomic absorption and DNA by the ethidium bromide assay .
bCells were counted using a hemocytometer.
cRheumatoid synovial cells.
d
e
f
Passage number (2) or (3).
Mean (range).
Cell number not determined.
gGST added to medium during confluency (C) or log phase (L).

hSkin cells.
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TABLE 5
R,ECOVER,Y OF B"IOCHEMICAL PARAMETERS AFTER GOLD SODIUM THIOMALATE (GST)
EXPOSED S,YNOVIAL CELLS ARE GROWN IN MEDIUM WITHOUT GST

E;ST treat....
ment CJ1MF --··

(m

Golda ·
moles)_

DNAb
(ug) .

Totalc
Protei~

(CPMXlO

6)

Collagen

c

( %)

a
Collagen
Type III
( %)

EXP le

O/Q

0

9.lf
(10.2-8.0)

0.38
(0.36-0.39)

12.6
(12 .4-12. 8)

18
(16-20)
8
13
(11-15)

10/10
10/0

18.3
8.7
(8. 7-8.6)

9.1
7.6
(5.9-9.2)

0.32
0.31
(0.31-0.31)

8.7
9.6
(9.5-9. 7)

30/ 30

149
(104-193)

3.7
(3.0-4.4)

0.13
(O .13-0 .13)

6.9
(6.8-7 .0)

47
(43-51)

3.0
(2.0-4.0)

0.21
(0.17-0.24)

6.8
(4.2-9.4)

9
(4-14)

30/0

7

EXP 2e
0

37.1
( 32. 6-41. 6)

4.0
(3.4-4.6)

9.8
(9.6-9.9)

18
(14-21)

10/10

15.0

33.5
(32.3-34.7)

3.2
( 3 .0-3. 5)

8.2
(7.5-8.9)

4

0/10

14.3

39
(37.9-40.0)

3.5
(3.1-3.9)

9.9
(8.4-11.4)

100/0

44.3

3.7
(3.0-4.3)

0.3
(0.3-0.4)

3.9
(3.4-4.3)

0/0

5
( 3-6)
g

aGold was quantitated using atomic absorption.
bDNA content was determined by the ethidium bromide assay.
cTotal protein and % collagen were determined by the collagenase digestible assay.
dcollagen type III % was determined radiometrically after separation
by electrophoresis.
eExposure time for Exp. 1 and 2 are the same as that on Table 4.
f

8

Mean (range) for two flasks.
Insufficient collagen for quantitation.
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percent type III collagen was not linearly related to gold
content per unit DNA or to gold content of flasks

(r

=

0.12).

The correlation coefficients for gold content versus biochemical parameters are not as high as GST medium concentrations
versus biochemical parameter (r > 0.90).
4.

Effect of GST on Cells during log phase and conflu-

ence.
In order to detennine the effect of confluency and
log phase on cells, second passage confluent cells (75 cm 2
flask) were subcultured.

After waiting one day for the sub-

cultured cells to attach, the medium of third passage log
phase cells and second passage confluent cells were exposed
to GST.

Table 6 shows the effect of GST on gold content,

proliferation, total protein, percent collagen and percent
type III collagen.

The -skin fibroblast doubling time was

approximately two days, therefore the GST exposure time was
less than the synovial cells.

With the synovial cells the

percent type III collagen produced was increased during log
phase growth whereas with the skin fibroblasts the percent
type III collagen produced was decreased.

With both cell

lines in conf luency or log phase the percent type III collagen decreased due to GST exposures.

GST did not decrease

the DNA content (more than 10%) during confluency, but depressed both when exposed during log phase growth.

In sy-

novial cells, GST induced a decrease in the total amount of
protein synthesized and a decrease in the percent collagen
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produced during log phase growth.
5.

Anti-rheumatic drugs and effects on GST.
The effect of hydroxycloroquine, dexarnethasone,

penicillamine and gold sodium thiomalate (GST) on the percentage of type III collagen produced by synovial cells after 10
days of exposure was measured in order to determine if other
anti-rheumatic drugs had GST-like effects on synovial cells.
Again, GST decreased the percentage of type III collagen by
SQ%; while the other anti-rheumatic drugs did not decrease
the

pe~cent

type III collagen synthesized.
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TABLE 6
EFFECT OF GOLD SODIUM THIOMALATE (GST) ON BIOCHEMICAL PARAMETERS OF
SYNOVIAL AND SKIN CELLS DURING LOG PHASE AND CONFLUENCY

GS Ta
(uM)

a)

Goldb
(m moles)

DNAC
(ug)

f

Totale
Protein
(CPMxl0- 6 )

Collagen

c

( %)

Collagen
Type III
( %)

Synovial cells during second and third passage (Exp. 3) .
Confluency

0
10
100

0
22
725

19.4g
21.5
18.8

2.2
2. 0
1. 7

2.0
1.6
1.1

13
8

4.0

23

2.6
(2.2-3.0)
2.5
(1. 8-3. 2)

9
( 7-11)

Log Phase
0
10
100

0
(0-0)
10
(9-11)
38
(38-39)

14.7h
1.3
(13. 3-16 .1)
0.9
12
(10 .6-13. 3) (O. 8-1. 0)
5.9
0.5
(3.6-8.2)
(0. 2-0. 8)

Skin fibroblast during second and third passage (Exp. 4) .

b)

Confluency
0

0

30

221

23.6
21.4

1.3
1.6

3.4
3.5

31

6.4
3.8

17

4

Log Phase
0

0

30

234

8.4
5.3

0 . 85
0.70

3

aExposure time for Exp. 3 and 4 are the same as in Table 4.
2
bGold associated with cell layer sonicates from (75 cm ) flasks was
quantitated by atomic absorption.
cDNA content was determined by ethidium bromide fluorescent assay.
dCells were counted using a hemocytometer.
eMedium total protein and % collagen was determined by the collagenase
digestible assay.
f Percent type III collagen was determined radiometrically after separation
by electrophoresis.
gSingLe determinations from one flask.

h

Mean (range) of two flasks.
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TABLE 7
EFFECT OF ANTI-RHEUMATIC DRUGS ON PERCENT TYPE III
COLLAGEN SYNTHESIZED BY CULTURED SYNOVIAL CELLS

Drug

Type IIIb
Collagen

(uM)

DNAc
(ug)

( %)

Control

13 + 2d

35 + 1

Hydroxycloroquine
(10)

19 + 5

31 + 1

Dexame thaso ne

12 + 1

27 + 4

Control

17 -+

5

14 + 3

Penicillamine
(20)

22 + 2

22 + 5

7 + 5

18 + 4

~10)

Gold Sodium
Thiomala te ( 10)

aCells were ~reincubated with the drug for 10 days, followed by 3 days
with drug, [~]-proline, BAPN and ascorbate before medium was harvested.
bType III collagen % has determined radiometricly after separation by
electrophoresis.
cCell layer sonicates were analyzed by the ethidium bromide DNA assay.
<\iean + SE for three flasks.
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V.

DISCUSSION

The efficacy of chrysotherapy (gold therapy) in inducing the remission of rheumatoid arthritis has been confirmed
by several controlled clinical studies (Sigler et al., 1974,
Research Subcommittee of the Empire Rheumatism Council, 1960,
1961 and Cooperative Clinics Committee of the American Rheumatism Association, 1973).

The present study demonstrates

that, in cultures of human synovial cells, gold sodium thiomalate (GST), at pharmacologically relevant concentrations,
has a direct effect on cells derived from the synovial tissues of patients with rheumatoid arthritis.

Serum gold con-

centrations of 1 to 3 ug/ml have been reported in rheumatoid
arthritic patients during chrysotherapy.

This is equivalent

to 5-15 uM GST. Synovial tissue gold concentrations are approximately 20-30 ug/g, which are equivalent to 100-150 uM
GST.

Thus, the concentrations used to treat cells in cul-

ture in these experiments were intermediate between the serum
and tissue concentrations observed during chrysotherapy
(Gerber et al., 1972; Mascarehas et al., 1972; Jessop and
Johns, 1973; Rubinstein and Dietz, 1973 and Gottlieb et al.,
1972; Vernon-Roberts et al., 1976).

Lipsky and Ziff (1972)

have shown that the gold moiety of GST or gold chloride inhibits lymphocyte proliferation (thiomalic acid was without
effect) .

None of the GST effects reported here were observed

when sodium thiomalate was added to the medium.

Therefore
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in accord with Lipsky and Ziff (1977), the gold moiety is responsible for the observed changes in synovial cell morphology,
proliferation and collagen synthesis.
No one experimental model has all the characteristics of
human RA.

The :rrodel used in this investigation to study the

effects of GST on the proliferative lesion of RA, was the synovial cell explant cell culture model from human rheumatoid
synovial tissue.

The advantages of this model are:

the cells

used in culture are the cells most likely responsible for the
proliferative lesion in RA, experiments can be conducted in
a convenient and controlled manner, and biochemical effects
due to GST can be detected more rapidly (days) in culture
than clinical benefit in patients' joints (months). The limitations are:

the cells selected are the more rapidly divid-

ing cells, the immunological and inflammatory cells and factors are not present, and, after subculturing, an extracellular matrix is reformed by·the synovial cells.

These limita-

tions are advantageous in this investigation because the
focus of this study is on the direct effect of GST on the
proliferating synovial cells and the extracellular matrix
formed by these cells.
This model does not deal with the complex interactions
of the immunological, inflammatory and synovial cells.

Con-

versely, the cell population generated by this culture technique is heterogeneous (Marsh et al., 1974) so the biochemical effects measured could be due to a selectivity for certain
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cell populations.

The interpretation of drug induced changes

in synovial cell metabolism in the flask to the RA joint has
the limitations of relating an in vitro to an in vivo condition.
Protein bound drugs in the serum are usually inactive
and the amount of free drug is usually correlated with pharmacological activity.

Albumin bound gold and gold denatured

proteins (Gerber, 1964) may be phagocytosed by gold neutrophils and monocytes.

This may be another reason in addition

to increased blood flow, that an inflamed synovium accumulates more gold than a nonrheumatoid joint (Grahme et al.,
1974). The accumulation of gold in kidney, liver and the reticuloendothelial system (Gottlieb et al.) may be due to the
phagocytosis and filtration of gold aggregated and denatured
proteins.

Thiomalate is more rapidly eliminated than the

gold moiety of GST (Jellum et al., 1980).

Hence, the dis-

tribution of gold in the body may be more dependent upon the
gold-protein aggregates than upon the free parent compound
GST.
The pharmacodynamic receptor(s) for gold has (have) not
been identified.

The fact that gold can form stable coor-

dination complexes with a variety of ligands (sulfur> carbon
and nitrogen)

(Harvey, 1976) would imply an immense number

of possible binding sites.

There are several billion mole-

cules of gold bound per cell (Table 4).

Therefore, much of

the binding, for example albumin, is not related to the mechanism of action.
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GST causes a morphological change in cells both in culture and in tissues.

Exposure of synovial cells to GST con-

taining medium causes dose dependent vacuole formation (Fig.
1) as observed by light microscopy, which are gold containing
membrane bound vesicles by EM (Fig. 2) and resembles the aurosomes in patients' tissues (Fig. 4).

In the case of synovial

tissues observed after administration of GST to RA patients,
the predominant cell type in which aurosomes occur is a phagocytic macrophage cell type (Fig. 4a & b), whereas in the explant culture system, the fibroblast like cells contained the
aurosomes (Figs. 2 and 3). Ghadially (1979) and Norton et al.
(1968)have previously reported that aurosomes occur in the
phagocytic cells of the synovium after in vivo exposure to
GST.

The cultured fibroblast like synovial cells used here

also have phagocytic properties, as demonstrated by the increase in cell size after exposure to latex particles (Table
2) or following exposure to GST (Fig. 7a) •

In the synovium

the cells more specific for phagocytosis would be expected
to take up more gold protein aggregates.

The kidney, liver

and adrenals have higher gold concentrations than the synovi um (Gottlieb et al., 1972). Therefore, the highest concentration of gold in a cell type or in a tissue does not identify the cell or the tissue as the target for the therapeutic agent.
The macrophage may be involved in both the mechanism of
action of gold and in the processing of gold for distribution.
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In the macrophage, the aurosomes could inhibit the degradative enzymes (Persillin and Ziff, 1966) or inhibit phagocytosis (Ugai et al., 1979). Fig. 3 shows a proposed maturation of the aurosome.

The gold precipitants or aggregates

enter the cell via phage- or pinnocytosis.

The protein

moiety of the aggregates in vacuoles may be dissolved by proteases, thereby leaving low molecular weight soluble gold
complexes that may interact within either the phagocytic
cell itself or be passed directly to another cell type (possibly a type B synoviocyte) and where biochemical changes
result (Goldberg et al., 1980). Also, a dead phagocyte may
release gold into the extra cellular matrix where binding
to the collagen occurs (Adam et al., 1965 and 1968) reforming
protein aggregates which may then be phagocytized by an adjacent type B sunoviocyte.

GST has been shown to interfere

with the proliferation of lymphocytes by interfering with
the macrophage function (Lipsky and Ziff, 1977).

Macrophages

process antigens for presentation to lymphocytes for antibody and lymphokine production.

The possibility exists that

macrophages assist in the clinical benefit of gold by processing gold aggregates and presenting them to a target cell
(the proliferating type B synoviocyte) , in this way preventing the growth of synovial cells of the enlarging pannus.
The hypothesis that processed gold-protein aggregates
are digested in the lysosomes and may interact with cytoplasmic proteins or other cellular components is supported
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by the gold distribution study of Lawson et al.

(1977).

In

the lysosomes they found a wide range of molecular weight
species, whereas in the cytoplasm several distinct peaks of
bound gold were found.

This finding would be expected if

high molecular weight gold-protein aggregates were in the
process of being digested.

The low molecular weight gold

or free gold would leave the lysosome and bind to certain
proteins with a high affinity for gold.

Van De Stadt and

Abbo-Tilstra (1980) found that at low gold concentrations
(<l ug/ml) gold preferentially binds to proteins other than
albumin. Thus, it is feasible that the lysosomes are processing the high molecular weight aggregates by degrading the
protein moiety and releasing soluble complexes that could
bind to cytoplasm "macromolecules."
Heavy metals in general have an antiproliferative effect, but this is the first time the mechanism of action of
gold in rheumatoid arthritis has been linked to the antiproliferative effect on hyperplastic synovial cells.

The onset

of the antiproliferative effect of GST takes several days.
No significant difference in cell number was found until
after 5 days of GST exposure.

No significant difference in

DNA content was found until after 4 days of GST exposure,
while a change in DNA synthesis was seen after 2 days.

The

onset delay of inhibition of DNA synthesis is correlated
with the accumulation of gold in the cell layer (Fig. 7).
This would indicate that gold needs to be internalized
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(Fig. 3) prior to the inhibition of proliferation or the occurrence of aurosome formation.

The delay of onset (which

is observed clinically since several months of gold therapy
is necessary before clinical benefits are seen) argues for
the presence of an internal receptor which provides a less
rapid onset than a cell surface receptor (Passow et al.,
1959).

The growth curve for both cell number (Fig. 6) and

DNA (Fig. 8a) shows continued cell growth for precisely
one doubling before inhibition by GST.

The C3 HJthyrnidine

inhibition preceded the DNA content decrease (Fig. 10) which
implies inhibition before or during S phase of the cell cycle.
The DNA content per cell increases with GST implying inhibition after S phase but before M phase (possibly G2 phase) .
To determine where in the cell cycle gold inhibits, a cloned
cell line that can be syncronized would be necessary.

To

date, no clones have been developed from the synovium.

The

inhibition of cell proliferation may be related to the nuclear change in Fig. 5.

Penney et al.

(1976) found 195Au in

nuclear subcellular fractions though this could have been
due to lysosomal contamination.

Ghadially (1979) reported

accumulation of bismuth and lead in the nucleus of cells but
not gold.

There has been no report of gold in the nucleus

by X-ray probe analysis.

In the present study, an X-ray

probe analysis of one electron dense area in the nucleus
failed to detect gold.

This would indicate the majority of

the electron dense area as chromatin clumps rather than gold
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but it is also possible there was not enough gold to detect
by X-ray analysis.

Gold may be bound to DNA, RNA or proteins

in the nucleus but the amount found in the nucleus is far
less than the gold in the aurosomes.

The data presented here

suggest that aurosomes participate in the transport and processing of gold and the primary site of action is the nucleus.
The decrease in protein synthesis per flask (Fig. 10)
like proliferation, is an effect common to most heavy metals
and could be just heavy metal toxicity.

However, the change

in protein synthesis per DNA was byphasic with the transition
for the concentration dependent decrease the same as the
threshold concentration for aurosome formation.

GST caused

a concentration dependent decrease in the percentage of collagen to total protein synthesized by synovial cells (Fig. 12).
Peniacillamine has also been shown to decrease the percent
of collagen to total protein synthesized by skin fibroblasts
in culture (Shorn et al., 1979), but the concentration of
peniacillamine used in culture for this study was far higher
than those obtained clinically.
The influence of cell crowding on collagen and protein
synthesis has been studied in a number of

labora~ories.

Mann (1971) and Steinberg (1978) both found a decrease in
total protein synthesis and an increase in the percentage of
collagen synthesized by 3T6 mouse fibroblasts from log phase
to confluency. Steinberg (1978) found an increase rate of
collagen synthesis in 3T6 during confluency; Priest and
Davis (1969) using 3T6 and rat PR105 cell lines and Abe
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et al.

(1979) using guinea pig skin fibroblasts found a de-

crease rate of collagen synthesis from log phase to confluency.
Both human synovial cells and human skin fibroblast produce
less protein per unit of DNA during confluency and an even
greater decrease in collagen protein synthesis was found during confluency (Table 6) .

Gold depresses the percentage of

collagen synthesized by synovial cells in both log phase and
~onfluency

and by skin cells in log phase only.

The increase in collagen synthesized per cell as detected by the collagenase digestable assay (Fig. 12 and
Table 6) was also found when the medium collagens were separated on SDS-polyacrylamide gels (Fig. 15).

The increase in

collagen was found to be predominantly type I collagen with
the dose dependent increase for type III collagen at a lower
slope than type I collagen (Fig. 15).

The percentage of

type III collagen to total collagen was found to be lower
(p< 0.05) in gold exposed (7.5-30 uM) cultures than untreated
controls when separated by both SDS-gel electrophoresis and
carboxymethyl cellulose chromatography (Table 3) .
Hance and Crystal (1978) reported that guinea pig lung
fibroblasts produce the same ratio of III/I collagens with
passages and cell density.

Parrott et al.

(1980) found that

osteoarthritis, normal and rheumatoid arthritis derived synovial cells produce a similar ratio of III/I with passage.
With the osteoarthritis and normal synovial cells a downward trend with passage was found, and with rheumatoid
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arthritis synovial cells an increase trend was found (but not
statistically significant).

Abe et al.

(1970) reported an

increased percent type III collagen synthesis during confluency for human and guinea pig skin fibroblasts.

This obser-

vation was confirmed in Table 6 for human skin fibroblast but
the opposite was true for synovial cells.

The percent of

type III collagen synthesized was decreased by GST in both
skin fibroblasts and synovial cells in both
confluency.

lo~

phase and

Also, in an experiment in which cell number was

unchanged due to the low GST concentration (7.SuM) a decrease
in type III collagen was also found • . Therefore, the change
in the percent synthesis of type III collagen is not due to
cell density changes.
The quantitation of medium collagen, by the fluorescent
method used here, represents the accumulation of [

14

C]pro-

line into collagen a chains in the synovial cell medium over
a 5 day period.

The measurement of total accumulation cir-

curnvents interpretation problems with regard to the influence of pool size changes and amino acid transport deficiencies on label incorporation which may be altered by gold
(Finkelstein

~t

The radioactive values repre-

al., 1977).

sent the incorporation of [

14

c]proline into collagen a

chains during a 2 day incubation and subsequent separation
of the radioactive collagen chains by both SDS-polyacrylamide gel electrophoresis and carboxyrnethyl cellulose
chromatography.

The exposure of human synovial cells to
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GST caused a decrease in the percentage of type III collagen
synthesized (as detected by both separation techniques) and
also in the percentage of type III collagen which accumulates
in the medium (based on the quantitation of media collagen
by fluorescent gel scanning techniques).

In view of this,

and the premise that the production of both type I and type
III collagen is dependent on the same precursor pools, indicates that the direct effect of gold on amino acid transport
or pool specific activity is not responsible for the changes
in collagen synthesis reported here.
The biochemical mechanism by which gold compounds alter
proliferation and collagen synthesis in synovial cells can
only be postulated from these experiments.

The cell popula-

tion generated by this culture technique is heterogeneous
(Marsh et al., 1974, Smith, 1971, Castor, 1970) so that the
dose-dependent effect of GST on proliferation and, therefore,
also on collagen synthesis could be due to a selectivity for
certain cell populations.

The alteration in collagen types

observed here could be due to direct stimulation of the synthesis of type I collagen, but we cannot rule out the possible inhibition of intracellular degradation (Bienkwski et
al., 1978).

Granulocyte collagenase has been shown to pre-

ferentially degrade type I as compared to type II! collagen
(Horowitz et al .. , 1977).

Therefore, intracellular inhibition

of a similar enzyme may result in the secretion of increased
amounts of type I collagen.
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A pannus can be considered a form of granulation tissue.

Gay et al.

(1978) demonstrated by irnmunofluorescence that

type III collagen is the early collagen laid down in granulation tissue followed by type I collagen.

In contrast, the

predominant collagen type in normal scar is type I collagen
(Bailey et al., 1973, 1975).

A pannus responds to inflama-

tion by generating granulation tissue, and further maturation
results in the formation of scar tissue. Thus, it is conceivable that the alteration of the composition of the synovial matrix is related to or dictates the functional nature
of the synovium in rheumatoid arthritis.

Recent preliminary

experiments by Dayer (personal communication) indicate that
a blood mononuclear cell factor may stimulate proline incorporation into collagen, with the preferential stimulation of
a protein tentatively identified as type III procollagen.
Parrott (manuscript in preparation) found an increaase in the
percentage of type III collagen synthesized by cultured
synovial cells after mononuclear cell factor stimulation.
The data reported here estali.lish that GST has a direct
effect on synovial cell proliferation, and on the amount and
nature (genetic composition) of the extracellular matrix
they produce.

This shift in synthesis or accumulation of

type I collagen over type III collagen may represent a switch
from a proliferative granulation tissue to end stage scar
tissue.

This forced maturation may in fact be responsible

for aborting the progressive proliferative component of the
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rheumatoid arthritis lesion, and may represent one of the important mechanisms responsible for the therapeutic efficacy
of gold therapy in the treatment of rheumatoid arthritis .
Ugai et al.

(1979) reported in vitro aurosome formation

in monocytes at doses similar to those used here to form aurosomes.

However, biochemical changes in cultured synovial

cells were found below the dose for vacuole (i.e., aurosome)
formation.

GST-induced vacuoles appeared to be irreversible

(present after subculturing and for a month without GST in
the medium) and biochemical recovery and elimination of gold
(Figs. 6, 8 and 9; Tables 4 and 5) was only partial at doses
that would cause vacuole formation.

Patients withdrawn from

gold therapy usually have a relapse or reactivation of RA
after several months (Freyberg, 1972).

Gold does decrease in

the synovial tissue after patients are withdrawn from chrysotherapy but is still present years later, as measured by atomic absorption spectrometry (Grahme et al., 1974) and as
found by EM (Fig. 4) and X-ray probe analysis (Ghadially et
al., 1978).

Vernon Roberts et al.

(1976) using neutron ac-

tivation analyzed the localization of GST in the synovium.
During chrysotherapy gold was abundant in synovial lining
cells.

Twenty-three years after stopping chrysotherapy gold

was found in the subsynovial connective tissue.
The presence of aurosomes or the presence of gold in
tissues does not imply a level of pharmacological activity
compatible with clinical benefit.

The presence of gold in

the cell layer after removal of GST from the medium for 4-14
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days (Table 4) was significantly correlated (r =0.57) with
biochemical changes (Table 5) but not to the degree observed
when GST was present in the medium (r> 0.9)

(Fig. 7-12).

Thus, the gold-induced suppression in the percentage of type
III collagen synthesized and cell proliferation return after
removal of GST from the medium at low (10 uM) but not high
(lOOuM) GST.
The GST induced morphological change of the synovial
cells in culture has a direct correlation to the morphological change in patients' synovial cells due to chrysotherapy.
This lends credence to the experimental model as one in
which there is a similar processing of gold in the cell cultures as in the rheumatoid joint.

The biochemical effects

of inhibition of proliferation and shift in collagen metabolism to the formation of a matrix not conducive for expansion
may be a mechanism by which gold causes remission of RA.
The means by which these biochemical alterations occur can
only be speculated.
Steroids are known to bind to a cytoplasm receptor. The
drug-receptor is modified to an "active complex"and enters
the nucleus.

Gold is internalized by cells, highly protein

bound, effects DNA replication and gene expression.

It is

unlikely that the sequestered gold in the aurosomes can have
these effects on the nucleus.

Thus, the processing of gold

in the aurosomes may be a means of forming an "active complex" similar to the "active complex" with steroids.
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Another means by which these biochemical effects of gold
on synovial cells may occur is by blocking or denaturing
necessary factors for cell proliferation and metabolism.
Lastly, the biochemical effects of gold have striking
similarities to the biochemical changes due to aging.

Gold

decreases the solubility of the collagen matrix by increasing cross-linkages of collagen (Adam et al., 1965 and 1968).
With age, there is an increase in collagen crosslinkages
(Bailey and Shimokomaki, 1971; Davison and Patel, 1975).
Gold decreases the relative percent of collagen synthesized
by cells in culture.

With age, there is a decrease in the

relative percentage of collagen synthesized in animal tissues and cells in culture (Newman and Lagner, 1975; Paz and
Gallop, 1975).

An age dependent shift from a type III col-

lagen predominance to a type I collagen predominance was
found from fetal to adult skin (Epstein, 1974).
a dose-dependent increase in type I collagen.

GST causes
Nontransforrned

cells in culture have an aging process in which proliferation
slows down and stops after a finite number of doublings.

An

increase in cell size and DNA content per cell has also been
found by aging cells in culture (Greenberg et al., 1977; Pee,
1970; Cristofalo et al., 1969).

GST has an antiprolifera-

tive effect in which there is an increase in cell size and
an increase in DNA content per cell.

Therefore, a quicker

maturation of the pannus granulation tissue is a means by
which expansion of the hyperplastic synovial cells into other connective tissue components of the joint can be inhibited,
and may be an explanation of the efficacy of gold in rheumatoid arthritis.
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VI.

CONCLUSION

Gold sodium thiomalate (GST) causes biochemical and morphological changes in cultured synovial cells at pharmacologically relevant concentrations (10-lOOuM) which may be related to the efficacy of gold treatments to rheumatoid arthritis patients.
1.

GST causes an analogous morphological change, auro-

somes, in cultured human synovial cells as iri. the synovial
tissue of patients.

Hence, processing of gold in vivo and

in vitro are similar.
2.

Clinically, GST prevents the hyperplasia of the syn-

ovial cells in joints of patients with RA and inhibits cell
division in cultured human synovial cells.

The inhibition

is reversible at low gold concentration (lOuM) but not at
high gold concentration (lOOuM) in culture.
3.
proteins.

GST alters the synthesis of extracellular matrix
The shift in the synovial cell synthesis from

collagen to noncollagen protein and from a type III collagen (new, repair) to a type I collagen (end stage, scar)
would cause the formation of an unfavorable matrix scaffold
for pannus expansion.

The recovery of the cell to synthe-

size type III collagen was found when GST (lOuM) was removed
from the medium.
Therefore, a mechanism of action of gold in rheumatoid
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arthritis can be a direct effect on synovial cells.

The gold

induced alterations in extracellular matrix formation and
the gold induced anti-proliferation of the synovial cells may
work synergistically to halt the pannus.

The clinical bene-

fits obtained from gold therapy, in a complex disase like
rheumatoid arthritis, lie in a specturrn of mechanisms working
on a variety of receptors and cells in concert.

The direct

effect of GST on synovial cells could be instrumental in preventing irreversible joint damage.
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VI I.

.-\ppendix
A. Cell lines used i n expe riment s .
Cell Line

Patient
Initials

Age
Sex (y rs )

Date of
Biopsy

Area of
BioESV

Diagnosis

RA-l 7S

A.T.

M

69

9 / 15 / 78

L . hip
s y noviurn

RA

RA-l4S

A.P.

F

60

9/ 20 / 78

L.hip
s y noviurn

RA

RA-18S

C.P.

F

26

9/ 17/ 78

L . wrist
s y noviurn

RA

RA-19S

A.P.

F

60

9/ 22/ 78

L . hip
synoviurn

RA

RA-16S

C.M.

F

53

9/ 13/ 78

R. knee
synoviurn

RA

RA-21S

L.N.

F

54

8/ 30 / 78

R.hip
synoviurn

RA

RA-13S

E.H.

M

66

11 / 28 / 77 R.knee
s y noviurn

RA

RA-15S

L.N.

F

54

8/ 30 /7 8

R.knee
synoviurn

RA

RA-23

J .R.

F

9/5 / 79

L.knee
synoviurn

RA

RA-15

J . F.

M

62

8/ 29 / 79

L.hip
synoviurn

RA

RA-16

O.B.

F

66

10 / 2/ 79

R.knee
synoviurn

RA

RA-26

F.B.

F

74

12 / 12 / 79 R.knee
synoviurn

RA

RA-25

G.H.

F

12 / 11/ 79 R.knee
synoviurn

RA

RA-27

A.B.

F

71

1/ 15/ 80

R.knee
synoviurn

RA

RA-30

G.D.

F

53

1/ 30 / 80

knee
synoviurn

RA

NS-17

G.-C.

M

31

9 / 4/ 79

R.knee
synoviurn

Normal

OA-16

v.s.

F

59

8/ 28/7 9

R . hip
synoviurn

OA

F

90

1 2/ 10 / 79 skin

PY-0

Normal
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